<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31559012</article-id>
<article-id pub-id-type="pmc">6743253</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.18926.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evolving principles underlying neural lineage conversion and their relevance for biomedical translation</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; peer review: 4 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Flitsch</surname>
<given-names>Lea Jessica</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brüstle</surname>
<given-names>Oliver</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding Acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2746-6519</contrib-id>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1">
<label>1</label>Institute of Reconstructive Neurobiology, University of Bonn School of Medicine &amp; University Hospital Bonn, Bonn, North Rhine Wesphalia, 53127, Germany</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:brustle@uni-bonn.de">brustle@uni-bonn.de</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>8</volume>
<elocation-id>F1000 Faculty Rev-1548</elocation-id>
<history>
<date date-type="accepted">
<day>23</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2019 Flitsch LJ and Brüstle O</copyright-statement>
<copyright-year>2019</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-8-20746.pdf"></self-uri>
<abstract>
<p>Scientific and technological advances of the past decade have shed light on the mechanisms underlying cell fate acquisition, including its transcriptional and epigenetic regulation during embryonic development. This knowledge has enabled us to purposefully engineer cell fates
<italic>in vitro</italic> by manipulating expression levels of lineage-instructing transcription factors. Here, we review the state of the art in the cell programming field with a focus on the derivation of neural cells. We reflect on what we know about the mechanisms underlying fate changes in general and on the degree of epigenetic remodeling conveyed by the distinct reprogramming and direct conversion strategies available. Moreover, we discuss the implications of residual epigenetic memory for biomedical applications such as disease modeling and neuroregeneration. Finally, we cover recent developments approaching cell fate conversion in the living brain and define questions which need to be addressed before cell programming can become an integral part of translational medicine.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Cell programming</kwd>
<kwd>Direct conversion</kwd>
<kwd>Transdifferentiation</kwd>
<kwd>Forward programming</kwd>
<kwd>In vivo conversion</kwd>
<kwd>Translation</kwd>
<kwd>Disease modelling</kwd>
<kwd>Transplantation</kwd>
</kwd-group>
<funding-group>
<award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/501100002347">
<funding-source>Bundesministerium für Bildung und Forschung</funding-source>
<award-id>01EK1603A-Neuro2D3</award-id>
</award-group>
<award-group id="fund-2" xlink:href="http://dx.doi.org/10.13039/100000002">
<funding-source>National Institutes of Health</funding-source>
<award-id>R01NS100514</award-id>
</award-group>
<award-group id="fund-3">
<funding-source>ERA-Net Neuron program</funding-source>
<award-id>01EW1812A</award-id>
</award-group>
<award-group id="fund-4">
<funding-source>European Union</funding-source>
<award-id>FP7-HEALTH-F4-2013-602278</award-id>
<award-id>H2020-667301</award-id>
</award-group>
<funding-statement>This work was supported by grants from the European Union (FP7-HEALTH-F4-2013-602278-Neurostemcellrepair and H2020-667301-Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders-COSYN), the German Federal Ministry of Education and Research (grant 01EK1603A-Neuro2D3), the ERA-Net Neuron program (grant 01EW1812A-Synaptic Dysfunction in Intellectual Disability Caused by SYNGAP1-TREAT-SNGAP), and the National Institutes of Health (R01 NS100514).</funding-statement>
<funding-statement>
<italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/browse/f1000-faculty-reviews">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Agnete Kirkeby</named-content>, Human Neural Development, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Jerome Mertens</named-content>, Institute of Molecular Biology, CMBI, Leopold-Franzens-University Innsbruck, Innsbruck, Austria
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Kristin Baldwin</named-content>, Department of Neuroscience, The Scripps Research Institute, La Jolla, California, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Andrew Yoo</named-content>, Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec>
<title>An introduction to cell programming and lineage conversion</title>
<p>The term cellular programming describes the modulation of transcriptional networks underlying cell identity. Research on cell programming has a remarkable history. First reports describing the principal feasibility of converting one cell type into another were published as early as 1987, when Davis, Weintraub, and Lassar derived myoblasts by overexpressing the myoblast transcription factor (TF) Myod3 in a mouse fibroblast line
<sup><xref ref-type="bibr" rid="ref-1">1</xref></sup>. However, at that time, cellular programming was restricted to the conversion of lineage-related cells of the same germ layer (see the 2009 review by Graf and Enver
<sup><xref ref-type="bibr" rid="ref-2">2</xref></sup>). This changed dramatically when Kazutoshi Takahashi and Shinya Yamanaka revealed that overexpression of the four TFs Oct3/4, Sox2, Klf4, and c-Myc is sufficient to induce a pluripotent state in mouse
<sup><xref ref-type="bibr" rid="ref-3">3</xref></sup> and human
<sup><xref ref-type="bibr" rid="ref-4">4</xref></sup> fibroblasts (for a more detailed review, see
<xref ref-type="bibr" rid="ref-5">5</xref>). Today, protocols are available to obtain these embryonic stem cell (ESC)-like induced pluripotent stem cells (iPSCs) from various species and starting cell types.</p>
<p>The success of the iPSC approach demonstrated that cell programming is not restricted to the conversion of related cell types and fueled attempts to achieve somatic-to-somatic cell conversion across germ layers. One avenue pursued in this direction has been the combination of time-restricted expression of the classic iPSC reprogramming TF cocktails with growth factors and small molecules promoting neural lineage development. An exemplar for such a “partial” reprogramming is the Oct3/4-, Sox2-, Klf4-, and c-Myc-driven derivation of neural stem cells (NSCs) from fibroblasts
<sup><xref ref-type="bibr" rid="ref-6">6</xref>–
<xref ref-type="bibr" rid="ref-10">10</xref></sup> or blood cells
<sup><xref ref-type="bibr" rid="ref-11">11</xref></sup>, where transgene expression was combined with an exposure to FGF2, FGF4, and/or EGF
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-7">7</xref>,
<xref ref-type="bibr" rid="ref-10">10</xref>,
<xref ref-type="bibr" rid="ref-11">11</xref></sup>, FGF2 and/or EGF in conjunction with LIF
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>, or LIF in combination with the TGFβ-inhibitor SB431542 and the GSK3β-inhibitor CHIR99021
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>. It is worth mentioning that in accordance with the transient expression of TFs used for generating iPSCs, partial reprogramming to NSCs may involve a short transit through a pluripotency-like state and can result in mixed cultures of iPSCs and NSCs
<sup><xref ref-type="bibr" rid="ref-12">12</xref>,
<xref ref-type="bibr" rid="ref-13">13</xref></sup>. Interestingly, such a pluripotency transit can also occur without forced Oct4 expression. Lineage tracing using an Oct4 reporter revealed that NSCs derived by overexpression of Sox2, Klf4, and c-Myc in conjunction with the neural-specific TF Brn4 instead of Oct4—a protocol originally published by Han
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-14">14</xref></sup> in 2012—originate from Oct4-expressing iPSC-like cells
<sup><xref ref-type="bibr" rid="ref-12">12</xref></sup>. Such a pluripotency transit can be used to mechanistically discriminate partial reprogramming from direct cell fate conversion (hereafter also denoted as transdifferentiation) based on the overexpression of lineage-specific TFs.</p>
<p>A major breakthrough concerning transdifferentiation across germ layers was in 2010, when the group of Marius Wernig succeeded in inducing neurons from mouse fibroblasts by overexpressing the neural lineage-specific TFs Ascl1, Brn2, and Myt1l
<sup><xref ref-type="bibr" rid="ref-15">15</xref></sup>. Soon thereafter, conversion of human fibroblasts to induced neurons (iNs) was achieved by using exactly this ASCL1, BRN2, and MYT1L TF combination
<sup><xref ref-type="bibr" rid="ref-16">16</xref>,
<xref ref-type="bibr" rid="ref-17">17</xref></sup>; ASCL1, BRN2, and MYT1L in conjunction with NEUROD1
<sup><xref ref-type="bibr" rid="ref-18">18</xref></sup>; or BRN2 and MYT1L together with the neuronal microRNA miR124
<sup><xref ref-type="bibr" rid="ref-19">19</xref></sup> (
<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" orientation="portrait" position="anchor">
<label>Table 1. </label>
<caption>
<title>Transcription factor–based generation of induced neurons
<italic>in vitro</italic>.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Derived cell type</th>
<th align="left" colspan="1" rowspan="1">Starting cell type</th>
<th align="left" colspan="1" rowspan="1">Species</th>
<th align="left" colspan="1" rowspan="1">Transcription factors used for
<break></break>reprogramming</th>
<th align="left" colspan="1" rowspan="1">Reference</th>
</tr>
<tr>
<th align="left" colspan="5" rowspan="1">Trans-germ layer conversion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="24" valign="top">Neurons (generic)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vierbuchen
<italic>et al</italic>. (2010)
<sup><xref ref-type="bibr" rid="ref-15">15</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts,
<break></break>Hepatocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Marro
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adler
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-45">45</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2 and Myt1l or Ascl1, Brn2,
<break></break>Ngn2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meng
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Li
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-47">47</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Several (CRISPR activation screen)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Liu
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-48">48</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Several (TF screen)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsunemoto
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts (
<italic>in situ</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Torper
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR124, BRN2, MYT1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ambasudhan
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-19">19</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L, NEUROD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pang
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-18">18</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfisterer
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-17">17</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR9/9* and miR124 (+ ASCL1, MYT1L
<break></break>and/or NEUROD2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yoo
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-51">51</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NGN2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ladewig
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR-124 regulated ASCL1, BRN2, MYT1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lau
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-53">53</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pereira
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">shp16 and/or shp19 or hTERT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sun
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NGN2 (Ladewig
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mertens
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR9/9*, miR124 (Yoo
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-51">51</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huh
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-57">57</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L (Pereira
<italic>et al</italic>.
<break></break>(2014)
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfisterer
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NGN2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smith
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-59">59</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2 (+ shRNA REST)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Drouin-Ouellet
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-60">60</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NGN2 (Mertens
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-61">61</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NGN2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Herdy
<italic>et al</italic>. (2019)
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Microglia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurod1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Matsuda
<italic>et al</italic>. (2019)
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">Glutamatergic
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chanda
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hu
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-64">64</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">BRN2, MYT1L, FEZF2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miskinyte
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-65">65</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">GABAergic
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adipose-derived
<break></break>stem cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Park
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-66">66</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shi
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-67">67</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pericytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, SOX2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Karow
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-33">33</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pericytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, SOX2 (Karow
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-33">33</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Karow
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-34">34</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6" valign="top">Midbrain
<break></break>dopamine-like
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Nurr1, Lmx1a, Pitx3, Foxa2, En1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Nurr1, Lmx1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caiazzo
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts (
<italic>in situ</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l, Lmx1a, Lmx1b,
<break></break>Foxa2, Otx2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Torper
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L, LMX1A, FOXA2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pfisterer
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-16">16</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, BRN2, MYT1L, LMX1A, LMX1B,
<break></break>FOXA2, OTX2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pereira
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NURR1, LMX1A, miR124
<break></break>(+shp53)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jiang
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Striatal medium
<break></break>spiny neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR9/9*, miR124, CTIP2, DLX1, DLX2,
<break></break>MYT1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Victor
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR9/9*, miR124, CTIP2, DLX1, DLX2,
<break></break>MYT1L (Victor
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Victor
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Serotonergic
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NGN2, NKX2.2, FEV, GATA2,
<break></break>LMX1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vadodaria
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-73">73</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, FEV, LMX1B, FOXA2 (+ shp53)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xu
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-74">74</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5" valign="top">Motoneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l, Ngn2, Lhx3, Hb9, Isl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ichida
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l, Ngn2, Lhx3, Hb9,
<break></break>Sox1, Pax6, Nkx6.1, Olig2 (+ Isl1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Son
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-76">76</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NGN2, SOX11, ISL1, LHX3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Liu
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR9/9*, miR124, ISL1, LHX3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abernathy
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-78">78</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">NGN2, SOX11, ISL1, LHX3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tang
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-79">79</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Sensory neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brn3a, Ngn1 or Brn3a, Ngn2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Blanchard
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-80">80</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Myt1l, Ngn1, Isl2, Klf7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wainger
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-81">81</xref></sup>
</td>
</tr>
<tr>
<th align="left" colspan="5" rowspan="1">Intra-germ layer conversion</th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="7" valign="top">Neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ngn2 or Ascl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Berninger
<italic>et al</italic>. (2007)
<sup><xref ref-type="bibr" rid="ref-40">40</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ngn2 or Ascl1 or Dlx2 (+ Ascl1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Heinrich
<italic>et al</italic>. (2010)
<sup><xref ref-type="bibr" rid="ref-82">82</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1 (+ Bcl2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gascón
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-83">83</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes (
<italic>in situ</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Torper
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT4, SOX2, or NANOG</td>
<td align="left" colspan="1" rowspan="1" valign="top">Corti
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">miR302/367</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ghasemi-Kasman
<italic>et al</italic>.
<break></break>(2015)
<sup><xref ref-type="bibr" rid="ref-42">42</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-43">43</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Midbrain
<break></break>dopamine-like
<break></break>neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes (
<italic>in situ</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Brn2, Myt1l, Lmx1a, Lmx1b,
<break></break>Foxa2, Otx2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Torper
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-50">50</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASCL1, NEUROD1, LMX1A, miR218</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rivetti di Val Cervo
<italic>et al</italic>.
<break></break>(2017)
<sup><xref ref-type="bibr" rid="ref-84">84</xref></sup>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>While direct transdifferentiation into a neuron remains a fascinating concept, the applicability of this approach can be limited by the fact that neurons are post-mitotic, thereby restricting large-scale applications. In addition, since not all cells undergo successful transdifferentiation, elimination of partially reprogrammed cells remains an issue. Finally, each transdifferentiated neuron represents a singular event and thus cannot be subjected to common batch control-based quality-control regimens, limiting the degree of standardization that can be reached with iN cultures. In light of this, expandable NSCs or neural progenitor cells (NPCs) could offer an interesting alternative. Indeed, several groups reported on the successful transdifferentiation of mouse
<sup><xref ref-type="bibr" rid="ref-20">20</xref>,
<xref ref-type="bibr" rid="ref-21">21</xref></sup> and human
<sup><xref ref-type="bibr" rid="ref-22">22</xref>–
<xref ref-type="bibr" rid="ref-27">27</xref></sup> fibroblasts into still-proliferative NSCs or NPCs using different NSC-enriched TFs or TF combinations (
<xref ref-type="table" rid="T2">Table 2</xref>). Subsequently, other somatic cells, too, were found to be amenable to direct neural conversion. In this context, easily accessible cell populations such as blood-derived
<sup><xref ref-type="bibr" rid="ref-28">28</xref>–
<xref ref-type="bibr" rid="ref-31">31</xref></sup> and urine-derived
<sup><xref ref-type="bibr" rid="ref-32">32</xref></sup> cells are of particular interest. Alongside converting non-central nervous system (non-CNS)-resident cells, there has been significant progress with neural conversion of non-neural, CNS-resident cells such as brain pericytes
<sup><xref ref-type="bibr" rid="ref-33">33</xref>,
<xref ref-type="bibr" rid="ref-34">34</xref></sup> and yolk sac-born microglia
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>, which both represent attractive candidates for
<italic>in vivo</italic> reprogramming. In parallel, transdifferentiation of astrocytes—which can be regarded as derivatives of neurogenic radial glia cells at the end of neural development (for further details on the relationship of radial glia cells, NSCs, and neurogenesis, see Falk and Götz
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>)—has been rapidly developing
<sup><xref ref-type="bibr" rid="ref-37">37</xref>–
<xref ref-type="bibr" rid="ref-39">39</xref></sup>, although most studies have been focusing on transdifferentiating astrocytes
<italic>in vivo</italic> (see “Destabilizing and converting cell fates
<italic>in vivo</italic>” section below and
<xref ref-type="table" rid="T3">Table 3</xref>). As for the
<italic>in vitro</italic> conversion of astrocytes into neurons, Benedikt Berninger, Magdalena Götz, and colleagues already showed in 2007 that this can be achieved by overexpression of the single neurogenic TF Ngn2 or Ascl1
<sup><xref ref-type="bibr" rid="ref-40">40</xref></sup>. In the meantime, additional paradigms based on TF combinations
<sup><xref ref-type="bibr" rid="ref-41">41</xref></sup>, microRNAs
<sup><xref ref-type="bibr" rid="ref-42">42</xref></sup>, or small molecules
<sup><xref ref-type="bibr" rid="ref-43">43</xref></sup> (or a combination of these) have been reported for astrocyte-to-neuron conversion.</p>
<table-wrap id="T2" orientation="portrait" position="anchor">
<label>Table 2. </label>
<caption>
<title>Approaches for the direct
<italic>in vitro</italic> conversion of somatic cells into neural stem cells/neural progenitor cells.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Starting cell type</th>
<th align="left" colspan="1" rowspan="1" valign="top">Species</th>
<th align="left" colspan="1" rowspan="1" valign="top">Transcription factors used for reprogramming</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
<tr>
<th align="left" colspan="4" rowspan="1" valign="top">Trans-germ layer conversion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cord blood cells (CD133
<sup>+</sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, c-MYC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Giorgetti
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-28">28</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cord blood cells (CD133
<sup>+</sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Castano
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-29">29</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cord blood cells (CD34
<sup>+</sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Liao
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-85">85</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cord blood cells (CD34
<sup>+</sup>),
<break></break>Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, HMGA2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yu
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-24">24</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cord blood cells (CD34
<sup>+</sup>),
<break></break>Peripheral blood cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, c-MYC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sheng
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-30">30</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral blood cells (CD34
<sup>+</sup>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT3/4, SOX2, KLF4, c-MYC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wang
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-11">11</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral blood cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT4, SOX2, KLF4, c-MYC, LIN28, NANOG, SV40LT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tang
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-86">86</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral blood cells,
<break></break>Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, KLF4, BRN2, ZIC3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thier
<italic>et al</italic>. (2019)
<sup><xref ref-type="bibr" rid="ref-31">31</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4, Sox2, Klf4, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim
<italic>et al</italic>. (2011)
<sup><xref ref-type="bibr" rid="ref-6">6</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brn4, Sox2, Klf4, c-Myc (+ Tcf3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Han
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-14">14</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brn2, Sox2, Foxg1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lujan
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-20">20</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4, Sox2, Klf4, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Matsui
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cheng
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-87">87</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4, Sox2, Klf4, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thier
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-7">7</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sox2, c-Myc, Brn2, Nr2e, Bmi1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tian
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-21">21</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Han
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-88">88</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brn4, Sox2, Klf4, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-89">89</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhang
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-90">90</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zheng
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-91">91</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sox2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ring
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-22">22</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ptf1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xiao
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-27">27</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pig</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4, Sox2, Klf4, l-Myc, Lin28</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xu
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-92">92</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Monkey, Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4, Sox2, Klf4, c-Myc</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lu
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, PAX6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maucksch
<italic>et al</italic>. (2012)
<sup><xref ref-type="bibr" rid="ref-93">93</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT4, SOX2, KLF4, c-MYC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meyer
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-10">10</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oct4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zhu
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-94">94</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mirakhori
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-95">95</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT3/4, SOX2, KLF4, l-Myc, LIN28, shp53</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capetian
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-96">96</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">ZFP521</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shabazi
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-25">25</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">CBX2, HES1, ID1, TFAP2A, ZFP42, ZNF423 or FOXG1,
<break></break>GATA3, NR2A2, PAX6, SALL2, TFAP2A, ZFP42</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hou
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-26">26</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2, PAX6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Connor
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-97">97</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fibroblasts</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">Exosomes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lee
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-98">98</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Urine cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">OCT4, SOX2, KLF4, SV40LT, miR302-367</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wang
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-32">32</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mesenchymal stem cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim
<italic>et al</italic>. (2018)
<sup><xref ref-type="bibr" rid="ref-99">99</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adipose-derived stem cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human</td>
<td align="left" colspan="1" rowspan="1" valign="top">None (chemical reprogramming)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Park
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-66">66</xref></sup>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" orientation="portrait" position="anchor">
<label>Table 3. </label>
<caption>
<title>Approaches for neural conversion
<italic>in vivo</italic>.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Derived cell type</th>
<th align="left" colspan="1" rowspan="1">Starting cell type</th>
<th align="left" colspan="1" rowspan="1">Transcription factors used for
<break></break>reprogramming</th>
<th align="left" colspan="1" rowspan="1">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">Neurons (generic)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Proliferating non-neuronal cells
<break></break>Reactive astrocytes
<break></break>Reactive astrocytes
<break></break>Reactive astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ngn2
<break></break>OligVP16 or Pax6
<break></break>OligVP16 or Pax6
<break></break>Ascl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Grande
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-100">100</xref></sup>
<break></break>Buffo
<italic>et al</italic>. (2005)
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>
<break></break>Kronenberg
<italic>et al</italic>. (2010)
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup>
<break></break>Faiz
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-101">101</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Astrocytes
<break></break>Astrocytes
<break></break>Astrocytes
<break></break>Astrocytes
<break></break>Astrocytes
<break></break>Astrocytes
<break></break>Astrocytes, NG2 cells
<break></break>Reactive astrocytes, NG2 cells
<break></break>Reactive astrocytes, NG2 cells
<break></break>NG2 cells
<break></break>Microglia
<break></break>Neurons (layer IV to V)
<break></break>Neurons (layer II/III to V)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sox2
<break></break>Sox2
<break></break>miR302/367
<break></break>Ascl1
<break></break>Sox2 (Niu
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-102">102</xref></sup>)
<break></break>Sox2 and shp53 or shp21
<break></break>Ascl1, Nurr1, and Lmx1a
<break></break>Neurod1
<break></break>Ngn2 (+ Bcl2)
<break></break>Sox2 (+ Ascl1)
<break></break>Neurod1
<break></break>Fezf2
<break></break>Fezf2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Niu
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-102">102</xref></sup>
<break></break>Su
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-103">103</xref></sup>
<break></break>Ghasemi-Kasman
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-42">42</xref></sup>
<break></break>Liu
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-104">104</xref></sup>
<break></break>Niu
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-105">105</xref></sup>
<break></break>Wang
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-106">106</xref></sup>
<break></break>Torper
<italic>et al</italic>. (2015)
<sup><xref ref-type="bibr" rid="ref-107">107</xref></sup>
<break></break>Guo
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-108">108</xref></sup>
<break></break>Gascon
<italic>et al</italic>. (2016)
<sup><xref ref-type="bibr" rid="ref-83">83</xref></sup>
<break></break>Heinrich
<italic>et al</italic>. (2014)
<sup><xref ref-type="bibr" rid="ref-109">109</xref></sup>
<break></break>Matsuda
<italic>et al</italic>. (2019)
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>
<break></break>De la Rossa
<italic>et al</italic>. (2013)
<sup><xref ref-type="bibr" rid="ref-110">110</xref></sup>
<break></break>Rouaux and Arlotta (2013)
<sup><xref ref-type="bibr" rid="ref-111">111</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopaminergic neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reactive astrocytes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Neurod1, Lmx1a, and miR218</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rivetti di Val Cervo
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-84">84</xref></sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Interneurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">NG2 cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1, Nurr1, and Lmx1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pereira
<italic>et al</italic>. (2017)
<sup><xref ref-type="bibr" rid="ref-112">112</xref></sup>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Since the beginning of this century, the cell programming toolbox has expanded rapidly. The aims of this review are to concisely recapitulate recent advances in this field, to briefly sum up our current understanding of general mechanisms underlying cell fate conversion, to summarize commonalities and differences between the available methods, and to discuss their pros and cons with respect to biomedical applications such as disease modeling and neuroregeneration.</p>
</sec>
<sec>
<title>Boosting transdifferentiation efficiency and fine-tuning sublineage specification</title>
<p>The first seminal reports on transdifferentiating somatic cells into neurons raised strong interest to make this process more efficient and, in particular, to tailor it toward the generation of distinct neural subpopulations. Since neurons are generally post-mitotic, conversion efficiency is a major limiting factor. Several studies addressed this bottleneck. It has been shown that modulation of signaling pathways by small molecules significantly improves iN conversion. For example, combined inhibition of SMAD and GSK3 signaling in human fibroblasts by small molecules can increase iN purity and yield (percentage of neurons in relation to the initial number of plated cells) to up to 80% and 210%, respectively
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. Following up on this observation, Pfisterer
<italic>et al</italic>. screened five annotated compound libraries for small molecules positively affecting fibroblast-to-neuron transdifferentiation and identified additional pathways (for example, cAMP signaling), whose modulation can increase neuronal yield
<sup><xref ref-type="bibr" rid="ref-58">58</xref></sup>. More recently, Herdy
<italic>et al</italic>. reported that combining JAK2 inhibition (promoting cell cycle arrest and mesenchymal-to-epithelial transition) with integrin and RAF1 activation (facilitating morphological rearrangements) as well as HIF1α inhibition (fostering the switch from glycolysis to oxidative phosphorylation) efficiently improves human fibroblast-to-neuron conversion
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup>. Moreover, in inducible viral systems, delivering multiple programming factors by all-in-one, polycistronic vectors
<sup><xref ref-type="bibr" rid="ref-62">62</xref></sup> and including a recovery phase between viral transduction and transgene activation
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup> have been shown to increase conversion efficiency. Lastly, reducing reprogramming barriers in somatic cells, such as inhibiting REST signaling in human fibroblasts
<sup><xref ref-type="bibr" rid="ref-60">60</xref></sup>, overcoming senescence
<sup><xref ref-type="bibr" rid="ref-55">55</xref></sup>, or inducing epigenetic remodeling by
<italic>TET1</italic> activation
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>, has been reported to boost iN generation, too.</p>
<p>In addition to increasing iN conversion efficiency as such, the generation of defined neuronal subpopulations has been a key focus of this emerging field. While the initial TF combinations used for iN generation resulted primarily in excitatory neurons, these cultures also contained inhibitory GABAergic neurons
<sup><xref ref-type="bibr" rid="ref-18">18</xref>,
<xref ref-type="bibr" rid="ref-19">19</xref>,
<xref ref-type="bibr" rid="ref-35">35</xref>,
<xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-52">52</xref></sup>. However, some groups reported on iN paradigms that strongly enrich for either glutamatergic
<sup><xref ref-type="bibr" rid="ref-63">63</xref>–
<xref ref-type="bibr" rid="ref-65">65</xref></sup> or GABAergic
<sup><xref ref-type="bibr" rid="ref-33">33</xref>,
<xref ref-type="bibr" rid="ref-34">34</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref>,
<xref ref-type="bibr" rid="ref-67">67</xref></sup> neurons. With respect to potential clinical prospects, the controlled induction of midbrain dopamine neurons and striatal medium spiny neurons (MSNs)—the prime targets of Parkinson’s disease (PD) and Huntington’s disease (HD), respectively—remains a key focus. In order to derive dopaminergic iNs from human fibroblasts, the classic iN reprogramming cocktail of ASCL1, BRN2, and MYT1L can be combined with the dopaminergic fate-specifying TFs LMX1A and FOXA2
<sup><xref ref-type="bibr" rid="ref-17">17</xref></sup> or a further enriched combination of LMX1A, LMX1B, FOXA2, and OTX2
<sup><xref ref-type="bibr" rid="ref-50">50</xref>,
<xref ref-type="bibr" rid="ref-54">54</xref></sup>. Alternatively, Ascl1 alone has been shown to be sufficient to induce a dopaminergic fate in fibroblasts when combined with Nurr1 and Lmx1a
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>; Nurr1, Lmx1a, Foxa2, Pitx3, and En1
<sup><xref ref-type="bibr" rid="ref-68">68</xref></sup>; or Nurr1, Lmx1a, and miR124
<sup><xref ref-type="bibr" rid="ref-70">70</xref></sup>. For the derivation of MSNs, combined overexpression of the CNS-enriched miR9/9* and miR124 with MYT1L and the striatal TFs CTIP2, DLX1, and DLX2 was used to convert human fibroblasts into mainly DARPP32-positive GABAergic neurons
<sup><xref ref-type="bibr" rid="ref-71">71</xref></sup>. Direct conversion has also been used to generate serotonergic neurons
<sup><xref ref-type="bibr" rid="ref-73">73</xref>,
<xref ref-type="bibr" rid="ref-74">74</xref></sup> as well as peripheral sensory neurons
<sup><xref ref-type="bibr" rid="ref-80">80</xref>,
<xref ref-type="bibr" rid="ref-81">81</xref></sup> and motor neurons (MNs)
<sup><xref ref-type="bibr" rid="ref-75">75</xref>–
<xref ref-type="bibr" rid="ref-78">78</xref></sup> (see
<xref ref-type="table" rid="T1">Table 1</xref> for further details). A number of these directly converted neuronal subpopulations have been successfully used for
<italic>in vitro</italic> disease modeling
<sup><xref ref-type="bibr" rid="ref-72">72</xref>,
<xref ref-type="bibr" rid="ref-77">77</xref>,
<xref ref-type="bibr" rid="ref-81">81</xref></sup> and drug testing
<sup><xref ref-type="bibr" rid="ref-77">77</xref></sup> (for the use of iNs in disease modeling, see also Drouin-Ouellet
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-113">113</xref></sup>). In parallel to improving trans-germ layer conversion, the generation of neuronal subtypes from astrocytes has been refined. Pioneering studies by Berninger and Götz already indicated that overexpression of Ngn2 yields mostly glutamatergic neurons whilst direct conversion of astrocytes with Dlx2 results in neurons biased toward a GABAergic phenotype
<sup><xref ref-type="bibr" rid="ref-82">82</xref>,
<xref ref-type="bibr" rid="ref-114">114</xref></sup>. More recently,
<italic>in vivo</italic> transdifferentiation into neurons with a predominantly dopaminergic fate was achieved
<sup><xref ref-type="bibr" rid="ref-84">84</xref></sup>.</p>
<p>With regards to fine-tuning direct conversion paradigms, it is worth mentioning that experimental tools other than classic retroviral or lentiviral systems have been employed for the delivery of TFs or activation of endogenous reprogramming-inducing genes. These include non-integrating viruses
<sup><xref ref-type="bibr" rid="ref-30">30</xref>,
<xref ref-type="bibr" rid="ref-46">46</xref>,
<xref ref-type="bibr" rid="ref-53">53</xref></sup>, plasmids and episomal vectors
<sup><xref ref-type="bibr" rid="ref-45">45</xref>,
<xref ref-type="bibr" rid="ref-85">85</xref>,
<xref ref-type="bibr" rid="ref-86">86</xref>,
<xref ref-type="bibr" rid="ref-92">92</xref>,
<xref ref-type="bibr" rid="ref-94">94</xref>,
<xref ref-type="bibr" rid="ref-96">96</xref></sup>, pro-neural exosomes released upon ultrasound stimulation
<sup><xref ref-type="bibr" rid="ref-98">98</xref></sup>, mRNAs
<sup><xref ref-type="bibr" rid="ref-97">97</xref>,
<xref ref-type="bibr" rid="ref-99">99</xref></sup> and microRNAs
<sup><xref ref-type="bibr" rid="ref-51">51</xref></sup>, proteins
<sup><xref ref-type="bibr" rid="ref-93">93</xref>,
<xref ref-type="bibr" rid="ref-95">95</xref></sup>, or even transdifferentiation paradigms based solely on chemical cocktails
<sup><xref ref-type="bibr" rid="ref-47">47</xref>,
<xref ref-type="bibr" rid="ref-64">64</xref>,
<xref ref-type="bibr" rid="ref-66">66</xref>,
<xref ref-type="bibr" rid="ref-87">87</xref>–
<xref ref-type="bibr" rid="ref-91">91</xref></sup>.</p>
</sec>
<sec>
<title>Forward programming as fallout of transcription factor-based somatic cell fate conversion</title>
<p>Given the tremendous efficacy of TFs in converting somatic cell fates, it is not surprising that this concept has been rapidly adopted to instruct cell fates from pluripotent stem cells (PSCs), thereby replacing or supplementing classic differentiation paradigms using extrinsic factors. “Forward programming” approaches such as the overexpression of neurogenins (NGNs)
<sup><xref ref-type="bibr" rid="ref-115">115</xref>–
<xref ref-type="bibr" rid="ref-120">120</xref></sup> or ASCL1
<sup><xref ref-type="bibr" rid="ref-63">63</xref>,
<xref ref-type="bibr" rid="ref-121">121</xref></sup> in human PSCs significantly accelerate neuronal differentiation and maturation times. These PSC-derived human neurons have been shown to become electrophysiologically functional as early as two weeks after
<italic>NGN</italic> induction
<sup><xref ref-type="bibr" rid="ref-115">115</xref>,
<xref ref-type="bibr" rid="ref-116">116</xref></sup>, and synchronized network activity can be detected already after three weeks in culture
<sup><xref ref-type="bibr" rid="ref-122">122</xref></sup>. This acceleration is associated with an increased synchronization of the differentiation process, which facilitates disease modeling applications focusing on functional phenotypes as, for example, in schizophrenia and autism
<sup><xref ref-type="bibr" rid="ref-123">123</xref>,
<xref ref-type="bibr" rid="ref-124">124</xref></sup> and tuberous sclerosis and epilepsy
<sup><xref ref-type="bibr" rid="ref-115">115</xref>,
<xref ref-type="bibr" rid="ref-117">117</xref></sup>. As with somatic cell fate conversion, combined overexpression of classic neurogenic TFs with TFs promoting distinct regional fates can be used to further fine-tune the generation of distinct neuronal subtypes. For example, overexpression of ASCL1 along with the midbrain-associated TFs NURR1 and LMX1A in human iPSCs has been demonstrated to yield neuronal cultures enriched for TH-positive dopamine-like neurons
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup>. The TFs Ngn2 and Isl1 in combination with Lhx3 and Phoxa2 instruct mouse ESCs to differentiate into cholinergic spinal and cranial MNs, respectively
<sup><xref ref-type="bibr" rid="ref-126">126</xref></sup>.</p>
</sec>
<sec>
<title>A need for pioneers?</title>
<p>Pioneer TFs are defined as TFs being able to bind to and open up closed chromatin. Therefore, pioneer TFs can not only induce their own target genes in non-permissive epigenetic states but also enable binding and regulation of secondary TFs. By this mechanism, pioneers are thought to specifically orchestrate the acquisition of new cell fates. Dissecting the process of iN reprogramming, Wapinski
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-127">127</xref></sup> demonstrated in 2013 that Ascl1 acts as a neuronal pioneer TF exactly in this manner: Ascl1 binds almost the same target genes in NSCs and fibroblasts, although these sites are mostly in closed chromatin states in fibroblasts. In contrast to Ascl1, Brn2 and Myt1l preferentially bind to open and accessible chromatin regions. In the context of iN reprogramming with the Ascl1, Brn2, and Myt1l cocktail, Ascl1 at least partially mediates the recruitment of Brn2 and thereby regulates the binding of Brn2 to a proportion of its pro-neural target genes
<sup><xref ref-type="bibr" rid="ref-127">127</xref></sup>. Moreover, Ascl1 alone is, in principle, sufficient to induce a neuronal state in fibroblasts, although transdifferentiation with Ascl1 in conjunction with Brn2 and Myt1l is far more efficient and exhibits faster maturation dynamics
<sup><xref ref-type="bibr" rid="ref-63">63</xref></sup>.</p>
<p>It is worth mentioning that overexpression of different neuronal pioneer TFs in otherwise identical cellular contexts might lead to varying results. This was recently exemplified by Aydin
<italic>et al</italic>., who overexpressed Ascl1 or Ngn2 in isogenic mouse ESC lines
<sup><xref ref-type="bibr" rid="ref-128">128</xref></sup>. The authors report that although Ascl1 and Ngn2 did not differ in their capacity to target inaccessible (and accessible) genomic regions, their individual binding patterns are largely non-overlapping. In fact, 90% of all targeted sites were found to be differentially bound by the two TFs as a consequence of their bHLH domain-mediated specificity to distinct E-box motifs. As Ascl1 and Ngn2 both increase chromatin accessibility at their respective target sites, they recruit shared downstream TFs such as Brn2 to different genomic sites, thereby leading to distinct patterns of transcriptional activity. Thus, albeit equivalently inducing pan-neuronal genes, the divergent binding of Ascl1 and Ngn2 elicits distinct neuronal subtype-specific signatures
<sup><xref ref-type="bibr" rid="ref-128">128</xref></sup>.</p>
<p>Notably, the effect of a given pioneer TF in PSCs might be quite different from that in somatic cells. This was demonstrated in 2016 by Smith
<italic>et al</italic>., who studied the effect of NGN2 overexpression in human fetal fibroblasts
<sup><xref ref-type="bibr" rid="ref-59">59</xref></sup>. They revealed that although NGN2 is able to act as a pioneer TF in this transdifferentiation setting (that is, targeting regions in a closed chromatin state), converting fibroblasts into iNs with NGN2 alone is extremely inefficient. However, this low efficiency is significantly enhanced by the small molecules forskolin and dorsomorphin, which promote chromatin accessibility at pro-neural NGN2 binding sites. More specifically, forskolin and dorsomorphin enhance the enrichment of CREB1 at sites bound by NGN2, thereby inducing the expression of the pro-neural gene
<italic>SOX4</italic>. SOX4, in turn, elicits further downstream chromatin remodeling and consequently facilitates the activation of other pro-neural genes such as
<italic>NEUROD1</italic> and
<italic>NEUROD4</italic>
<sup><xref ref-type="bibr" rid="ref-59">59</xref></sup>. For other somatic cell types, different pioneer factors might be required to promote cell fate conversion. In mouse microglia, for instance, not Ngn2 or Ascl1 but Neurod1 acts as a neuronal pioneer TF, specifically inducing transcription of its bivalently marked pro-neural target genes
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>. Along the same lines, oligodendrocytes, which also feature bivalent histone modifications at pro-neural Neurod1 target genes, were successfully reprogrammed into neurons by Neurod1 overexpression
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>.</p>
<p>As the reprogramming field progressed, major advances were made in profiling cell fate trajectories by single-cell RNA sequencing (scRNAseq). Using this technology, Treutlein
<italic>et al</italic>. studied the conversion of mouse embryonic fibroblasts to iNs and specifically analyzed the contribution of the neuronal pioneer TF Ascl1 to the induction and stabilization of the fibroblast-to-iN fate switch in the Ascl1–Brn2–Myt1l paradigm
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>. Concordant with the results of Wernig’s group, they showed that overexpression of Ascl1 alone is sufficient to homogenously induce downregulation of fibroblast-enriched transcriptomic signatures, to upregulate the expression of neuronal genes, and to promote cell cycle exit. They found the continued expression of Ascl1 as well as co-expression of Brn2 and Myt1l to be essential for the stabilization of neuronal fate and subsequent neuronal maturation, whereas silencing of Ascl1 in the course of the conversion process resulted in the reappearance of fibroblast signatures
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>. Notably, the majority of Ascl1-only-induced cells do not acquire a neuronal identity, even if Ascl1 expression levels are maintained, but activate a myocyte-related transcriptional program
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup>. This observation might be explained by the lack of
<italic>Myt1l</italic> induction in Ascl1-only conditions. Mall
<italic>et al</italic>. investigated the role of this non-pioneer TF during fibroblast-to-neuron conversion and revealed that its main function is to interact with the Sin3b–HDAC1 complex to repress non-neuronal transcriptional programs
<sup><xref ref-type="bibr" rid="ref-130">130</xref></sup>. Myt1l-repressed targets include genes promoting proliferation, such as
<italic>Hes1</italic>, and genes inducing alternative lineages, including targets relevant for myocyte differentiation
<sup><xref ref-type="bibr" rid="ref-130">130</xref></sup>. Together, these data indicate that, in addition to pioneer factors, secondary fate-specifying or alternative fate-repressing cues (or both) are necessary to ensure proper phenotype stabilization. Consequently, Tsunemoto
<italic>et al</italic>. recently screened a library of 598 TF pairs for their ability to convert mouse embryonic fibroblasts into functional iNs
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. As expected, almost all successful combinations included at least one member of the Ascl, Ngn, or Neurod families. However, pairs of pro-neural TFs comprising no pioneer TF also yielded functional iNs, demonstrating that pioneer TFs are not an indispensable condition for direct cell fate conversion
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. Along similar lines, the group of Lei Qi performed a CRISPR activation screen to identify single TFs and TF combinations that promote differentiation of mouse ESCs and direct conversion of fibroblasts into neurons
<sup><xref ref-type="bibr" rid="ref-48">48</xref></sup>. In addition to known pro-neural TFs such as Ngns or Brn2, their top hits included non-pioneer TFs and even non-neural-specific TFs such as the epigenetic regulator Ezh2
<sup><xref ref-type="bibr" rid="ref-48">48</xref></sup>.</p>
<p>Taken together, the currently available data support a two-stage architecture of the conversion process. First, target cell type-specific genes need to be made accessible in case they are in an unfavorable chromatin state in the starting cell type. In addition to pioneer TFs, epigenetic modifiers or other factors modulating chromatin accessibility can exert this effect. Overexpression of miR9/9* and miR124, for instance, has been shown to promote gradual remodeling of chromatin accessibility at fibroblast-specific enhancers (change to closed chromatin) and chromatin opening at pan-neuronal gene loci
<sup><xref ref-type="bibr" rid="ref-78">78</xref></sup>. Second, after induction of epigenetic plasticity, acquisition and stabilization of a new cell fate have to take place. Although this process can be initiated and orchestrated by pioneer TFs too, it mostly involves additional TFs. These can be co-transduced in the starting cell along with the pioneer TF (that is, by overexpressing TF combinations) or induced by small molecules used to promote the direct conversion process or they are direct transcriptional targets of the pioneer TF and thus secondarily induced by the pioneer itself. Eventually, pioneer as well as non-pioneer TFs instruct the adoption of a specific cell fate through either active induction of target lineage-specific genes (as was demonstrated for, for example, Ascl1
<sup><xref ref-type="bibr" rid="ref-129">129</xref></sup> or Neurod1
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>) or transcriptional repression of genes instructing alternative cell fates (as shown for, for example, Myt1l
<sup><xref ref-type="bibr" rid="ref-130">130</xref></sup>). Notably, however, the process of fate acquisition might involve additional intermediate steps, since scRNAseq time-course analyses of the iN conversion process indicate the presence of transient, unstable progenitor-like identities before a stable neuronal phenotype is adopted
<sup><xref ref-type="bibr" rid="ref-34">34</xref>,
<xref ref-type="bibr" rid="ref-129">129</xref></sup>. As overarching mechanistic principles underlying cell fate conversion become increasingly uncovered, it is important to note that the exact mechanisms of fate switches will always comprise components highly specific to the identity of the interconverted cell types and the individual conversion paradigm.</p>
</sec>
<sec>
<title>Tampering with epigenetic age</title>
<p>The epigenetic memory of a cell falls into two major categories: cell fate and age. Since significant transcriptomic and epigenetic remodeling plays a pivotal role in the process of cell programming, it seems natural to ask how different programming paradigms affect a cell’s aging signature. However, age is a highly multi-faceted phenomenon and hard to assess by simple means (see the 2015 review by Studer, Vera, and Cornacchia
<sup><xref ref-type="bibr" rid="ref-131">131</xref></sup>). Some aspects of cellular aging, such as compromised nuclear architecture, cannot be easily assessed in a quantitative manner. Others, such as telomere length, might not strictly correlate with biological age, depending on the tissue context
<sup><xref ref-type="bibr" rid="ref-132">132</xref></sup>. One alternative way to estimate the biological age of a cell independent of its somatic cell fate is to analyze DNA methylation (DNAm) signatures and apply algorithms calculating a DNAm age
<sup><xref ref-type="bibr" rid="ref-133">133</xref></sup>. When applied to iPSC generation, DNAm ages have been shown to be reset upon induction of pluripotency, which is in line with the fact that iPSC reprogramming resets the starting cell’s identity back to an embryonic-like state
<sup><xref ref-type="bibr" rid="ref-133">133</xref>,
<xref ref-type="bibr" rid="ref-134">134</xref></sup>. Thus, somatic-to-iPSC reprogramming represents a tool to derive epigenetically rejuvenated cells. Conversely, in 2015, the groups of Yixuan Wang and Fred Gage demonstrated that aging hallmarks such as age-specific transcriptional signatures and the age-dependent loss of nucleocytoplasmic compartmentalization are preserved in mouse
<sup><xref ref-type="bibr" rid="ref-135">135</xref></sup> and human
<sup><xref ref-type="bibr" rid="ref-56">56</xref></sup> iNs, respectively. One year after these reports, it was demonstrated that the DNAm ages of iNs are retained, too, and almost perfectly correlate with their donors’ chronological ages
<sup><xref ref-type="bibr" rid="ref-57">57</xref></sup>. Over the last two years, several other studies corroborated the notion that age-associated cellular alterations such as senescence, susceptibility to DNA damage, mitochondrial defects, loss of heterochromatin, and alterations in nuclear organization are preserved in fibroblast-derived iNs
<sup><xref ref-type="bibr" rid="ref-61">61</xref>,
<xref ref-type="bibr" rid="ref-79">79</xref></sup>. These findings indicate that iNs maintain not only epigenetic but also functional age-related phenotypes of their cells of origin. Interestingly, all of these studies were conducted in a scenario where the converted cells immediately enter the post-mitotic stage of an iN. Thus, we became interested in the question of how age preservation would work upon transdifferentiation into a proliferative somatic stem cell population. Following up on this idea, we used temporary overexpression of SOX2 and c-MYC to convert adult peripheral blood cells into induced NSCs (iNSCs). Using the Horvath and other epigenetic age predictor algorithms, we found that iNSCs generated in this manner undergo massive epigenetic rejuvenation similar to what is observed during iPSC reprogramming
<sup><xref ref-type="bibr" rid="ref-30">30</xref></sup>. This observation is noteworthy, as our conversion approach is OCT4-free and there is no evidence of a transit through a pluripotent state. Although the mechanism underlying the reset of biological age remains to be unveiled, this finding strongly suggests that epigenetic rejuvenation does not require an intermediate pluripotent stage and can also be achieved during transdifferentiation of somatic cell types. This notion is further supported by very recent analyses of DNAm changes upon iPSC reprogramming, which show that the reset of DNAm age and the establishment of a stable and self-sustaining pluripotent state follow different time dynamics
<sup><xref ref-type="bibr" rid="ref-136">136</xref></sup>. From a conceptual point of view, these observations support the idea that epigenetic rejuvenation, in principle, can be achieved in somatic cells.</p>
<p>The question of whether or not reprogrammed cells preserve age signatures is especially relevant when it comes to modeling age-related diseases. In particular, successful modeling of neurodegenerative diseases might depend on the preservation of cellular defects naturally accumulating over an organism’s life span. The importance of age preservation for disease modeling was recently illustrated in the context of HD. The group of Andrew Yoo found that aggregation of the disease-causing mutant huntingtin protein can be readily recapitulated in directly converted MSNs but not in iPSC-derived MSNs, a phenomenon the authors attributed to the erasure of age signatures such as the restoration of proteasomal activity in iPSC-derived MSNs
<sup><xref ref-type="bibr" rid="ref-72">72</xref></sup>. Acknowledging that the lack of aging hallmarks in iPSC-derived somatic cells can impede modeling of age-associated pathophenotypes, strategies such as progerin overexpression or telomerase inhibition have been explored to promote the emergence of age-associated phenotypes
<sup><xref ref-type="bibr" rid="ref-137">137</xref>,
<xref ref-type="bibr" rid="ref-138">138</xref></sup>. Owing to their age memory, directly converted neurons might not require additional age-promoting treatments for modeling late-onset neurodegenerative diseases, for example. However, it is fair to say that iNs might, vice versa, be less suitable for modeling neurodevelopmental disorders.</p>
</sec>
<sec>
<title>Somatic memory and authenticity</title>
<p>Although some diseases affect neurons rather broadly, others are known to target preferentially specific subtypes such as PD, which is associated with a loss of mesencephalic dopaminergic neurons in the substantia nigra. Since cellular pathomechanisms might be cell type dependent, the authenticity of the transdifferentiated neural subpopulation might contribute significantly to the validity and power of cellular disease models. While there is evidence for low levels of residual somatic memory in low-passage iPSCs
<sup><xref ref-type="bibr" rid="ref-134">134</xref>,
<xref ref-type="bibr" rid="ref-139">139</xref>,
<xref ref-type="bibr" rid="ref-140">140</xref></sup>, these signatures appear to vanish after prolonged
<italic>in vitro</italic> cultivation
<sup><xref ref-type="bibr" rid="ref-140">140</xref></sup>. This presents differently in directly converted cells. Tsunemoto
<italic>et al</italic>. analyzed four fibroblast-derived iN populations reprogrammed by different TF combinations and revealed that although the global transcriptome of iNs is highly similar to that of endogenous neurons, all iN populations showed residual low-level expression of a subset of fibroblast-specific genes
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. Residual somatic signatures were also recently reported for iNSCs. Thier
<italic>et al</italic>. derived iNSCs with neural plate border identity from different populations of human fibroblasts and blood cells
<sup><xref ref-type="bibr" rid="ref-31">31</xref></sup>. They found that dermal fibroblast-derived but not blood-derived iNSCs still express the fibroblast marker
<italic>COL3A1</italic>, although other fibroblast-lineage markers are significantly downregulated upon transdifferentiation
<sup><xref ref-type="bibr" rid="ref-31">31</xref></sup>. Nevertheless, residual somatic signatures in directly converted cells appear to be insufficient to maintain the identity and function of the cell of origin. For example, hepatocyte-derived iNs were shown to retain more than 10% of the liver-specific transcriptomic signature, but resulting iNs are capable of neither secreting albumin nor producing urea
<sup><xref ref-type="bibr" rid="ref-44">44</xref></sup>.</p>
<p>However, the questions of whether and to what extent the function of the converted iNs can be compromised by residual somatic signatures of the donor cell certainly merit further investigation, and recent data suggest that authenticity is an issue not restricted to direct cell fate conversion. Ichida
<italic>et al</italic>. compared primary mouse spinal MNs with ESC-derived, iPSC-derived, and directly converted MNs and revealed that all
<italic>in vitro</italic>-derived MN populations, regardless of the reprogramming paradigm used, expressed only about 55% to 86% of the primary MN transcriptome
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>. These differences were accompanied by even more pronounced discrepancies in the methylation status
<sup><xref ref-type="bibr" rid="ref-75">75</xref></sup>. From a technical point of view, this study illustrates a fundamental bottleneck of contemporary cell fate reprogramming and conversion research: traditionally, cell fate identification has been based mostly on the expression of cell type-specific marker profiles, and, if applicable, further characteristic features such as specific functional properties, including electrophysiological data, have been considered. These approaches are biased, however, as they are hypothesis driven. More holistic approaches such as the in-depth analysis of transcriptomic data, ideally in single-cell resolution, and comparative methylation analysis, as performed by the Eggan lab, might represent means to provide more reliable and biologically meaningful measures of cell identity and authenticity. From a biological perspective, such findings also point to more general limitations of
<italic>in vitro</italic> cell systems in recapitulating
<italic>in vivo</italic> scenarios. On the other hand, it remains unclear what degree of somatic authenticity is eventually required to, for example, recapitulate disease-specific phenotypes—an issue which also depends on the specific experimental hypothesis. For other biomedical applications such as replacement of distinct neuronal subpopulations, utmost authenticity will always represent the ultimate goal.</p>
</sec>
<sec>
<title>Destabilizing and converting cell fates
<italic>in vivo</italic>
</title>
<p>Translation of
<italic>in vitro</italic> paradigms of direct cell fate conversion to an
<italic>in vivo</italic> scenario remains one of the most fascinating perspectives of regeneration. From a translational point of view, such approaches could eventually replace cell transplantation. From a biological perspective, transdifferentiation of region-specific cells in a native tissue environment might represent the ultimate approach to approximate authenticity.</p>
<p>In the CNS, the longest history of
<italic>in situ</italic> transdifferentiation has astrocyte-to-neuron conversion (
<xref ref-type="table" rid="T3">Table 3</xref>), starting with the observation that antagonizing Olig2 or overexpressing Pax6 after traumatic brain injury enables neurogenesis from resident reactive astrocytes
<sup><xref ref-type="bibr" rid="ref-37">37</xref></sup>; this phenomenon has also been recapitulated after infliction of mild brain ischemia
<sup><xref ref-type="bibr" rid="ref-38">38</xref></sup>. Similarly, Neurod1 has been shown to convert reactive astrocytes as well as NG2-positive progenitors into neurons in mouse stab injury and Alzheimer’s disease models
<sup><xref ref-type="bibr" rid="ref-108">108</xref></sup>. Heinrich
<italic>et al</italic>. demonstrated that retrovirus-mediated overexpression of Sox2 alone or in combination with Ascl1 transdifferentiates NG2 cells into neurons in the acutely injured cortex
<sup><xref ref-type="bibr" rid="ref-109">109</xref></sup>. Astrocyte-to-neuron conversion has also been achieved in the healthy, unlesioned rodent CNS, for example, by the overexpression of the pioneer TFs Ascl1
<sup><xref ref-type="bibr" rid="ref-101">101</xref>,
<xref ref-type="bibr" rid="ref-104">104</xref></sup> and Sox2
<sup><xref ref-type="bibr" rid="ref-102">102</xref>,
<xref ref-type="bibr" rid="ref-103">103</xref>,
<xref ref-type="bibr" rid="ref-106">106</xref></sup> or mediated by miR302/367
<sup><xref ref-type="bibr" rid="ref-42">42</xref></sup>.</p>
<p>As with
<italic>in vitro</italic> conversion,
<italic>in vivo</italic> transdifferentiation is being increasingly refined toward the generation of distinct neuronal subpopulations. Torper
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-107">107</xref></sup> tested the TF combination of Ascl1, Nurr1, and Lmx1a, which specifies dopaminergic-like neurons from human PSCs
<sup><xref ref-type="bibr" rid="ref-125">125</xref></sup> and fibroblasts
<sup><xref ref-type="bibr" rid="ref-69">69</xref></sup>
<italic>in vitro</italic>. Notably, although this TF cocktail successfully converted astrocytes and NG2 glia into neurons
<italic>in vivo</italic>, these neurons did not adopt a dopaminergic phenotype
<sup><xref ref-type="bibr" rid="ref-107">107</xref></sup>. Instead, this TF combination was found to promote the generation of interneurons exhibiting a fast-spiking parvalbumin-positive phenotype
<sup><xref ref-type="bibr" rid="ref-107">107</xref>,
<xref ref-type="bibr" rid="ref-112">112</xref></sup>, highlighting the necessity to re-assess tools developed
<italic>in vitro</italic> for their applicability
<italic>in vivo</italic>. The team of Ernest Arenas then showed that supplementation of the TF combination of Ascl1 and Lmx1a with Neurod1 and miR218 can successfully instruct the conversion of astrocytes to dopamine neurons, which alleviated gait impairments in a mouse model of PD
<sup><xref ref-type="bibr" rid="ref-84">84</xref></sup>, emphasizing the relevance of this approach for clinical translation. Recent work by Matsuda
<italic>et al</italic>. extended
<italic>in vivo</italic> transdifferentiation to mouse microglia, which they converted with Neurod1 into striatal projection neuron-like cells, which were electrophysiologically active and formed excitatory synapses with host neurons
<sup><xref ref-type="bibr" rid="ref-35">35</xref></sup>. Interestingly, even post-mitotic neurons appear to be amenable to TF-based fate shifting: the TF Fezf2 was shown to be competent of re-specifying post-mitotic mouse layer II/III callosal projection
<sup><xref ref-type="bibr" rid="ref-111">111</xref></sup> and layer IV spiny neurons
<sup><xref ref-type="bibr" rid="ref-110">110</xref></sup> into layer V corticofugal projection neurons.</p>
<p>Escalating the concept of TF-mediated
<italic>in vivo</italic> cell fate shifts, the results of several studies point to the possibility of reprogramming cells
<italic>in situ</italic> toward pluripotency
<sup><xref ref-type="bibr" rid="ref-141">141</xref>–
<xref ref-type="bibr" rid="ref-144">144</xref></sup>. Interestingly, in accordance with the concept of partial reprogramming, the group of Juan Carlos Belmonte demonstrated that short-term cyclic expression of Oct3/4, Sox2, Klf4, and c-Myc
<italic>in vivo</italic> does not lead to the establishment of a stable pluripotent fate but can increase the regenerative capacity of multiple organs in physiologically aged mice and promote cellular rejuvenation in progeria mice suffering from premature aging
<sup><xref ref-type="bibr" rid="ref-145">145</xref></sup>.</p>
</sec>
<sec>
<title>Challenges for clinical application</title>
<p>Even though
<italic>in vivo</italic> conversion is a promising strategy to exploit endogenous sources for cell replacement, a number of limitations have to be overcome before this approach is fit for clinical translation. First, the delivery of fate-instructing factors has to be good manufacturing practice compliant and applicable in living humans. Here, established viral vector systems successfully applied in gene therapy approaches such as adeno-associated viruses
<sup><xref ref-type="bibr" rid="ref-104">104</xref>,
<xref ref-type="bibr" rid="ref-107">107</xref>,
<xref ref-type="bibr" rid="ref-112">112</xref></sup> might represent an attractive solution. Alternatively, non-viral approaches such as transducible proteins, mRNAs, or small molecules might qualify for delivering the required cell programming cues
<italic>in vivo</italic> (for a review on recent technologies facilitating
<italic>in vivo</italic> reprogramming, see Larouche and Aguilar
<sup><xref ref-type="bibr" rid="ref-146">146</xref></sup>). Whatever delivery system is chosen, it has to enable factor distribution to the lesion site. For focal lesions, stereotaxic delivery can be considered, but more global cell loss might require modes of systemic administration that are not impeded by the blood–brain barrier. Moreover, dependent on the individual transdifferentiation regimen, multiple rounds of factor administration or delivery of depots such as scaffold-bound conversion factors might be necessary (reviewed in 2019 by Larouche and Aguilar
<sup><xref ref-type="bibr" rid="ref-146">146</xref></sup> and Bruggeman
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-147">147</xref></sup>).</p>
<p>
<italic>In vivo</italic> conversion is further complicated by the fact that this process can be strongly context dependent. Grande
<italic>et al</italic>. showed that Ngn2-mediated conversion of proliferating non-neuronal cells yields GABAergic neurons in the mouse striatum but results in the emergence of glutamatergic neurons in the neocortex
<sup><xref ref-type="bibr" rid="ref-100">100</xref></sup>. In addition, the local microenvironment can affect conversion efficiency. Wang
<italic>et al</italic>.
<sup><xref ref-type="bibr" rid="ref-106">106</xref></sup> found that decreasing p53–p21 signaling increases the yield of astrocyte-derived neuroblasts by preventing p53-induced cell cycle exit, while locally secreted neurotrophins can support their maturation
<sup><xref ref-type="bibr" rid="ref-105">105</xref></sup>. Götz and her team reported that counteracting oxidative stress and ferroptosis can significantly increase neuron derivation from glial cells
<italic>in vivo</italic>
<sup><xref ref-type="bibr" rid="ref-83">83</xref></sup>.</p>
<p>Another risk factor to be considered in the context of
<italic>in vivo</italic> conversion is the emergence of partially programmed cells, the potential tumorigenicity of such cells, and their potential impact on tissue homeostasis. Finally, as
<italic>in vivo</italic> conversion efficiencies increase, depletion of the target cell population can become a serious issue. This is particularly true for astrocytes, oligodendrocytes, and microglia, which serve a plethora of vital functions in tissue homeostasis and neuronal function. In this context, cells with residual self-renewal capacity might serve as particularly attractive targets for neuronal conversion.</p>
</sec>
<sec>
<title>Implications</title>
<p>Notwithstanding the many fundamental and translational questions that remain to be addressed in the context of direct cell fate conversion, this field provides fascinating prospects for a number of biomedical applications ranging from disease modeling via drug discovery to cell therapy and endogenous regeneration (
<xref ref-type="fig" rid="f1">Figure 1</xref>). For disease-related research, the prospect of age preservation in iNs could render these cells a preferred resource for patient-specific modeling of late-onset neurodegenerative disorders and establishing
<italic>in vitro</italic> systems for compound screening. As for regeneration, somatic cell fate conversion and TF-based forward programming of PSCs could enable intricate approaches for generating neural subtypes faster and with much higher precision than conventional methods. Finally,
<italic>in vivo</italic> transdifferentiation is about to revolutionize our concepts for neuroregeneration and, for some applications, might eventually substitute traditional cell transplantation strategies. However, although epigenetic remodeling is a general principle underlying cell programming, the preservation of somatic and age memory seems to be unique for each conversion paradigm. Thus, developing a better understanding of the mechanisms underlying specific conversion trajectories is essential in order to fully exploit this emerging technology for biomedical research and therapy.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
<label>Figure 1. </label>
<caption>
<title>Direct cell fate conversion strategies in the context of biomedical applications.</title>
<p>Depending on the choice of programming factors, direct conversion can be fine-tuned to derive different cell types and even distinct neuronal subtypes, which can serve as platforms for disease modeling and drug discovery or as donor source for neural transplantation. Notably, different cell fate programming paradigms are characterized by varying degrees of scalability (that is, cell yield), retention of epigenetic memory, and standardization (for example, cell culture homogeneity and feasibility to provide quality-controlled batches), which might influence their applicability for biomedical applications. In contrast to transplantation of
<italic>in vitro</italic>-derived cells,
<italic>in vivo</italic> cell fate conversion might enable restoration of neuronal circuitry from endogenous sources. NSC, neural stem cell; TF, transcription factor.</p>
</caption>
<graphic xlink:href="f1000research-8-20746-g0000"></graphic>
</fig>
</sec>
<sec>
<title>Abbreviations</title>
<p>Ascl1, Achaete-scute homolog 1; bHLH, basic helix–loop–helix; Brn2 aka POU3F2, POU domain class 3 transcription factor 2; Brn4 aka POU3F4, POU domain class 3 transcription factor 4; cAMP, cyclic adenosine monophosphate; CNS, central nervous system; c-Myc, avian myelocytomatosis viral oncogene cellular homolog; COL3A1, collagen type III alpha 1 chain; CREB1, cAMP responsive element-binding protein 1; CRISPR, clustered regularly interspaced short palindromic repeats; CTIP2 aka BCL11B, B-cell lymphoma/leukemia 11B; DARPP32 aka PPR1B, protein phosphatase 1 regulatory subunit 1B; Dlx, distal-less homeobox; DNAm, DNA methylation; EGF, epidermal growth factor; En, engrailed homeobox; ESC, embryonic stem cell; Ezh2, enhancer of zeste homolog 2; Fezf2, Fez family zinc finger protein 2; FGF, fibroblast growth factor; Fox, forkhead box; GABA, gamma aminobutyric acid; GSK, glycogen synthase kinase; HD, Huntington’s disease; HDAC1, histone deacetylase 1; Hes1, hairy and enhancer of split-1; HIF1α, hypoxia-inducible factor 1-alpha; iN, induced neuron; iNSC, induced neural stem cell; iPSC, induced pluripotent stem cell; ISL1, islet1; JAK2, Janus kinase 2; Klf4, Krueppel-like factor 4; LIF, leukemia inhibitory factor; LHX3; LIM homeobox 3; Lmx1, LIM homeobox TF 1; MN, motor neuron; MSN, medium spiny neuron; Myod3, myogenic differentiation 3; Myt1l, myelin transcription factor 1 like; Neurod1, neurogenic differentiation 1; NG2, neuron-glial antigen 2; NGN, neurogenin; NPC, neural progenitor cell; NSC, neural stem cell; NURR1, nuclear receptor related 1; Oct3/4, octamere-binding transcription factor 3/4; Olig, oligodendrocytes TF; OTX, orthodenticle homeobox; PAX, paired box protein; PD, Parkinson’s disease; PHOX2A, paired like homeobox 2A; PSC, pluripotent stem cell; Pitx, pituitary homeobox; RAF1, rapidly accelerated (rat) fibrosarcoma 1; REST, RE1 silencing TF; scRNAseq, single-cell RNA sequencing; Sin3b, SWI-independent transcription regulator family member b; Sox2/SOX4, sex determining region Y-box 2/4; TET, Ten-eleven translocation methylcytosine dioxygenase; TF, transcription factor; TGF, transforming growth factor; TH, tyrosine hydroxylase</p>
</sec>
</body>
<back>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>RL</given-names></name><name><surname>Weintraub</surname><given-names>H</given-names></name><name><surname>Lassar</surname><given-names>AB</given-names></name></person-group>:
<article-title>Expression of a single transfected cDNA converts fibroblasts to myoblasts.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>1987</year>;<volume>51</volume>(<issue>6</issue>):<fpage>987</fpage>–<lpage>1000</lpage>.
<pub-id pub-id-type="doi">10.1016/0092-8674(87)90585-x</pub-id>
<pub-id pub-id-type="pmid">3690668</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/13484060">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graf</surname><given-names>T</given-names></name><name><surname>Enver</surname><given-names>T</given-names></name></person-group>:
<article-title>Forcing cells to change lineages.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2009</year>;<volume>462</volume>(<issue>7273</issue>):<fpage>587</fpage>–<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1038/nature08533</pub-id>
<pub-id pub-id-type="pmid">19956253</pub-id></mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group>:
<article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2006</year>;<volume>126</volume>(<issue>4</issue>):<fpage>663</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2006.07.024</pub-id>
<pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/30699">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Ohnuki</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2007</year>;<volume>131</volume>(<issue>5</issue>):<fpage>861</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id>
<pub-id pub-id-type="pmid">18035408</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1096022">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hanna</surname><given-names>JH</given-names></name><name><surname>Saha</surname><given-names>K</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group>:
<article-title>Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2010</year>;<volume>143</volume>(<issue>4</issue>):<fpage>508</fpage>–<lpage>25</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2010.10.008</pub-id>
<!--<pub-id pub-id-type="pmcid">3032267</pub-id>-->
<pub-id pub-id-type="pmid">21074044</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Efe</surname><given-names>JA</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of mouse fibroblasts to neural progenitors.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2011</year>;<volume>108</volume>(<issue>19</issue>):<fpage>7838</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1103113108</pub-id>
<!--<pub-id pub-id-type="pmcid">3093517</pub-id>-->
<pub-id pub-id-type="pmid">21521790</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thier</surname><given-names>M</given-names></name><name><surname>Wörsdörfer</surname><given-names>P</given-names></name><name><surname>Lakes</surname><given-names>YB</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of fibroblasts into stably expandable neural stem cells.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2012</year>;<volume>10</volume>(<issue>4</issue>):<fpage>473</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2012.03.003</pub-id>
<pub-id pub-id-type="pmid">22445518</pub-id></mixed-citation>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsui</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency.</article-title>
<source/><italic toggle="yes">Stem Cells.</italic>
<year>2012</year>;<volume>30</volume>(<issue>6</issue>):<fpage>1109</fpage>–<lpage>19</lpage>.
<pub-id pub-id-type="doi">10.1002/stem.1091</pub-id>
<pub-id pub-id-type="pmid">22467474</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>CT</given-names></name><etal></etal></person-group>:
<article-title>Generation of integration-free and region-specific neural progenitors from primate fibroblasts.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2013</year>;<volume>3</volume>(<issue>5</issue>):<fpage>1580</fpage>–<lpage>91</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.04.004</pub-id>
<!--<pub-id pub-id-type="pmcid">3786191</pub-id>-->
<pub-id pub-id-type="pmid">23643533</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Ferraiuolo</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>CJ</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2014</year>;<volume>111</volume>(<issue>2</issue>):<fpage>829</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1314085111</pub-id>
<!--<pub-id pub-id-type="pmcid">3896192</pub-id>-->
<pub-id pub-id-type="pmid">24379375</pub-id></mixed-citation>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>E</given-names></name><name><surname>Monaco</surname><given-names>MC</given-names></name><etal></etal></person-group>:
<article-title>Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e81720</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0081720</pub-id>
<!--<pub-id pub-id-type="pmcid">3841177</pub-id>-->
<pub-id pub-id-type="pmid">24303066</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bar-Nur</surname><given-names>O</given-names></name><name><surname>Verheul</surname><given-names>C</given-names></name><name><surname>Sommer</surname><given-names>AG</given-names></name><etal></etal></person-group>:
<article-title>Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage.</article-title>
<source/><italic toggle="yes">Nat Biotechnol.</italic>
<year>2015</year>;<volume>33</volume>(<issue>7</issue>):<fpage>761</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/nbt.3247</pub-id>
<!--<pub-id pub-id-type="pmcid">4840929</pub-id>-->
<pub-id pub-id-type="pmid">26098450</pub-id></mixed-citation>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maza</surname><given-names>I</given-names></name><name><surname>Caspi</surname><given-names>I</given-names></name><name><surname>Zviran</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.</article-title>
<source/><italic toggle="yes">Nat Biotechnol.</italic>
<year>2015</year>;<volume>33</volume>(<issue>7</issue>):<fpage>769</fpage>–<lpage>74</lpage>.
<pub-id pub-id-type="doi">10.1038/nbt.3270</pub-id>
<!--<pub-id pub-id-type="pmcid">4500825</pub-id>-->
<pub-id pub-id-type="pmid">26098448</pub-id></mixed-citation>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>DW</given-names></name><name><surname>Tapia</surname><given-names>N</given-names></name><name><surname>Hermann</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of fibroblasts into neural stem cells by defined factors.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2012</year>;<volume>10</volume>(<issue>4</issue>):<fpage>465</fpage>–<lpage>72</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2012.02.021</pub-id>
<pub-id pub-id-type="pmid">22445517</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vierbuchen</surname><given-names>T</given-names></name><name><surname>Ostermeier</surname><given-names>A</given-names></name><name><surname>Pang</surname><given-names>ZP</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of fibroblasts to functional neurons by defined factors.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2010</year>;<volume>463</volume>(<issue>7284</issue>):<fpage>1035</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1038/nature08797</pub-id>
<!--<pub-id pub-id-type="pmcid">2829121</pub-id>-->
<pub-id pub-id-type="pmid">20107439</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1750956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfisterer</surname><given-names>U</given-names></name><name><surname>Kirkeby</surname><given-names>A</given-names></name><name><surname>Torper</surname><given-names>O</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of human fibroblasts to dopaminergic neurons.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2011</year>;<volume>108</volume>(<issue>25</issue>):<fpage>10343</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1105135108</pub-id>
<!--<pub-id pub-id-type="pmcid">3121829</pub-id>-->
<pub-id pub-id-type="pmid">21646515</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/12210957">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfisterer</surname><given-names>U</given-names></name><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>Nihlberg</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Efficient induction of functional neurons from adult human fibroblasts.</article-title>
<source/><italic toggle="yes">Cell Cycle.</italic>
<year>2011</year>;<volume>10</volume>(<issue>19</issue>):<fpage>3311</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.4161/cc.10.19.17584</pub-id>
<pub-id pub-id-type="pmid">21934358</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pang</surname><given-names>ZP</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Vierbuchen</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Induction of human neuronal cells by defined transcription factors.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2011</year>;<volume>476</volume>(<issue>7359</issue>):<fpage>220</fpage>–<lpage>3</lpage>.
<pub-id pub-id-type="doi">10.1038/nature10202</pub-id>
<!--<pub-id pub-id-type="pmcid">3159048</pub-id>-->
<pub-id pub-id-type="pmid">21617644</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/11577957">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ambasudhan</surname><given-names>R</given-names></name><name><surname>Talantova</surname><given-names>M</given-names></name><name><surname>Coleman</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2011</year>;<volume>9</volume>(<issue>2</issue>):<fpage>113</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2011.07.002</pub-id>
<!--<pub-id pub-id-type="pmcid">4567246</pub-id>-->
<pub-id pub-id-type="pmid">21802386</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/12650956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lujan</surname><given-names>E</given-names></name><name><surname>Chanda</surname><given-names>S</given-names></name><name><surname>Ahlenius</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2012</year>;<volume>109</volume>(<issue>7</issue>):<fpage>2527</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1121003109</pub-id>
<!--<pub-id pub-id-type="pmcid">3289376</pub-id>-->
<pub-id pub-id-type="pmid">22308465</pub-id></mixed-citation>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tian</surname><given-names>C</given-names></name><name><surname>Ambroz</surname><given-names>RJ</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors.</article-title>
<source/><italic toggle="yes">Curr Mol Med.</italic>
<year>2012</year>;<volume>12</volume>(<issue>2</issue>):<fpage>126</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="doi">10.2174/156652412798889018</pub-id>
<!--<pub-id pub-id-type="pmcid">3434966</pub-id>-->
<pub-id pub-id-type="pmid">22172100</pub-id></mixed-citation>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ring</surname><given-names>KL</given-names></name><name><surname>Tong</surname><given-names>LM</given-names></name><name><surname>Balestra</surname><given-names>ME</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2012</year>;<volume>11</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2012.05.018</pub-id>
<!--<pub-id pub-id-type="pmcid">3399516</pub-id>-->
<pub-id pub-id-type="pmid">22683203</pub-id></mixed-citation>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zou</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of human fibroblasts into neuronal restricted progenitors.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2014</year>;<volume>289</volume>(<issue>8</issue>):<fpage>5250</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M113.516112</pub-id>
<!--<pub-id pub-id-type="pmcid">3931081</pub-id>-->
<pub-id pub-id-type="pmid">24385434</pub-id></mixed-citation>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>KR</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name><etal></etal></person-group>:
<article-title>Rapid and Efficient Direct Conversion of Human Adult Somatic Cells into Neural Stem Cells by HMGA2/let-7b.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2015</year>;<volume>10</volume>(<issue>3</issue>):<fpage>441</fpage>–<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.038</pub-id>
<pub-id pub-id-type="pmid">25600877</pub-id></mixed-citation>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shahbazi</surname><given-names>E</given-names></name><name><surname>Moradi</surname><given-names>S</given-names></name><name><surname>Nemati</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2016</year>;<volume>6</volume>(<issue>4</issue>):<fpage>539</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2016.02.013</pub-id>
<!--<pub-id pub-id-type="pmcid">4834053</pub-id>-->
<pub-id pub-id-type="pmid">27052315</pub-id></mixed-citation>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hou</surname><given-names>PS</given-names></name><name><surname>Chuang</surname><given-names>CY</given-names></name><name><surname>Yeh</surname><given-names>CH</given-names></name><etal></etal></person-group>:
<article-title>Direct Conversion of Human Fibroblasts into Neural Progenitors Using Transcription Factors Enriched in Human ESC-Derived Neural Progenitors.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>54</fpage>–<lpage>68</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2016.11.006</pub-id>
<!--<pub-id pub-id-type="pmcid">5233298</pub-id>-->
<pub-id pub-id-type="pmid">27940274</pub-id></mixed-citation>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiao</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>2865</fpage>.
<pub-id pub-id-type="doi">10.1038/s41467-018-05209-1</pub-id>
<!--<pub-id pub-id-type="pmcid">6054649</pub-id>-->
<pub-id pub-id-type="pmid">30030434</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giorgetti</surname><given-names>A</given-names></name><name><surname>Marchetto</surname><given-names>MC</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2012</year>;<volume>109</volume>(<issue>31</issue>):<fpage>12556</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1209523109</pub-id>
<!--<pub-id pub-id-type="pmcid">3412010</pub-id>-->
<pub-id pub-id-type="pmid">22814375</pub-id></mixed-citation>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castaño</surname><given-names>J</given-names></name><name><surname>Menendez</surname><given-names>P</given-names></name><name><surname>Bruzos-Cidon</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Fast and efficient neural conversion of human hematopoietic cells.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2014</year>;<volume>3</volume>(<issue>6</issue>):<fpage>1118</fpage>–<lpage>31</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.10.008</pub-id>
<!--<pub-id pub-id-type="pmcid">4264063</pub-id>-->
<pub-id pub-id-type="pmid">25458894</pub-id></mixed-citation>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>C</given-names></name><name><surname>Jungverdorben</surname><given-names>J</given-names></name><name><surname>Wiethoff</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>4047</fpage>.
<pub-id pub-id-type="doi">10.1038/s41467-018-06398-5</pub-id>
<!--<pub-id pub-id-type="pmcid">6168501</pub-id>-->
<pub-id pub-id-type="pmid">30279449</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734151197">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thier</surname><given-names>MC</given-names></name><name><surname>Hommerding</surname><given-names>O</given-names></name><name><surname>Panten</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Identification of Embryonic Neural Plate Border Stem Cells and Their Generation by Direct Reprogramming from Adult Human Blood Cells.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2019</year>;<volume>24</volume>(<issue>1</issue>):<fpage>166</fpage>–<lpage>182.e13</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2018.11.015</pub-id>
<pub-id pub-id-type="pmid">30581079</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734676926">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Generation of integration-free neural progenitor cells from cells in human urine.</article-title>
<source/><italic toggle="yes">Nat Methods.</italic>
<year>2013</year>;<volume>10</volume>(<issue>1</issue>):<fpage>84</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nmeth.2283</pub-id>
<pub-id pub-id-type="pmid">23223155</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717968104">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karow</surname><given-names>M</given-names></name><name><surname>Sánchez</surname><given-names>R</given-names></name><name><surname>Schichor</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2012</year>;<volume>11</volume>(<issue>4</issue>):<fpage>471</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2012.07.007</pub-id>
<pub-id pub-id-type="pmid">23040476</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717999272">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karow</surname><given-names>M</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><name><surname>Falk</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2018</year>;<volume>21</volume>(<issue>7</issue>):<fpage>932</fpage>–<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1038/s41593-018-0168-3</pub-id>
<!--<pub-id pub-id-type="pmcid">6319609</pub-id>-->
<pub-id pub-id-type="pmid">29915193</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733461518">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>T</given-names></name><name><surname>Irie</surname><given-names>T</given-names></name><name><surname>Katsurabayashi</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2019</year>;<volume>101</volume>(<issue>3</issue>):<fpage>472</fpage>–<lpage>485.e7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.010</pub-id>
<pub-id pub-id-type="pmid">30638745</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734824701">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Falk</surname><given-names>S</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name></person-group>:
<article-title>Glial control of neurogenesis.</article-title>
<source/><italic toggle="yes">Curr Opin Neurobiol.</italic>
<year>2017</year>;<volume>47</volume>:<fpage>188</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1016/j.conb.2017.10.025</pub-id>
<pub-id pub-id-type="pmid">29145015</pub-id></mixed-citation>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buffo</surname><given-names>A</given-names></name><name><surname>Vosko</surname><given-names>MR</given-names></name><name><surname>Ertürk</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2005</year>;<volume>102</volume>(<issue>50</issue>):<fpage>18183</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0506535102</pub-id>
<!--<pub-id pub-id-type="pmcid">1312388</pub-id>-->
<pub-id pub-id-type="pmid">16330768</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1029597">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kronenberg</surname><given-names>G</given-names></name><name><surname>Gertz</surname><given-names>K</given-names></name><name><surname>Cheung</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Modulation of fate determinants Olig2 and Pax6 in resident glia evokes spiking neuroblasts in a model of mild brain ischemia.</article-title>
<source/><italic toggle="yes">Stroke.</italic>
<year>2010</year>;<volume>41</volume>(<issue>12</issue>):<fpage>2944</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.583039</pub-id>
<pub-id pub-id-type="pmid">21051674</pub-id></mixed-citation>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sirko</surname><given-names>S</given-names></name><name><surname>Behrendt</surname><given-names>G</given-names></name><name><surname>Johansson</surname><given-names>PA</given-names></name><etal></etal></person-group>:
<article-title>Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected].</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2013</year>;<volume>12</volume>(<issue>4</issue>):<fpage>426</fpage>–<lpage>39</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2013.01.019</pub-id>
<pub-id pub-id-type="pmid">23561443</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berninger</surname><given-names>B</given-names></name><name><surname>Costa</surname><given-names>MR</given-names></name><name><surname>Koch</surname><given-names>U</given-names></name><etal></etal></person-group>:
<article-title>Functional properties of neurons derived from
<italic>in vitro</italic> reprogrammed postnatal astroglia.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2007</year>;<volume>27</volume>(<issue>32</issue>):<fpage>8654</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1615-07.2007</pub-id>
<pub-id pub-id-type="pmid">17687043</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/1089423">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corti</surname><given-names>S</given-names></name><name><surname>Nizzardo</surname><given-names>M</given-names></name><name><surname>Simone</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of human astrocytes into neural stem cells and neurons.</article-title>
<source/><italic toggle="yes">Exp Cell Res.</italic>
<year>2012</year>;<volume>318</volume>(<issue>13</issue>):<fpage>1528</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1016/j.yexcr.2012.02.040</pub-id>
<!--<pub-id pub-id-type="pmcid">3405531</pub-id>-->
<pub-id pub-id-type="pmid">22426197</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghasemi-Kasman</surname><given-names>M</given-names></name><name><surname>Hajikaram</surname><given-names>M</given-names></name><name><surname>Baharvand</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-Mediated
<italic>In Vitro</italic> and
<italic>In Vivo</italic> Direct Conversion of Astrocytes to Neuroblasts.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>6</issue>):<fpage>e0127878</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0127878</pub-id>
<!--<pub-id pub-id-type="pmcid">4451260</pub-id>-->
<pub-id pub-id-type="pmid">26030913</pub-id></mixed-citation>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>JC</given-names></name><name><surname>Yeh</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>6</issue>):<fpage>735</fpage>–<lpage>47</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.09.012</pub-id>
<!--<pub-id pub-id-type="pmcid">4675726</pub-id>-->
<pub-id pub-id-type="pmid">26481520</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marro</surname><given-names>S</given-names></name><name><surname>Pang</surname><given-names>ZP</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Direct lineage conversion of terminally differentiated hepatocytes to functional neurons.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2011</year>;<volume>9</volume>(<issue>4</issue>):<fpage>374</fpage>–<lpage>82</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2011.09.002</pub-id>
<!--<pub-id pub-id-type="pmcid">3218088</pub-id>-->
<pub-id pub-id-type="pmid">21962918</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/13356005">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adler</surname><given-names>AF</given-names></name><name><surname>Grigsby</surname><given-names>CL</given-names></name><name><surname>Kulangara</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells.</article-title>
<source/><italic toggle="yes">Mol Ther Nucleic Acids.</italic>
<year>2012</year>;<volume>1</volume>:<fpage>e32</fpage>.
<pub-id pub-id-type="doi">10.1038/mtna.2012.25</pub-id>
<!--<pub-id pub-id-type="pmcid">3411320</pub-id>-->
<pub-id pub-id-type="pmid">23344148</pub-id></mixed-citation>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>Q</given-names></name><etal></etal></person-group>:
<article-title>Induction of fibroblasts to neurons through adenoviral gene delivery.</article-title>
<source/><italic toggle="yes">Cell Res.</italic>
<year>2012</year>;<volume>22</volume>(<issue>2</issue>):<fpage>436</fpage>–<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1038/cr.2011.185</pub-id>
<!--<pub-id pub-id-type="pmcid">3271579</pub-id>-->
<pub-id pub-id-type="pmid">22105483</pub-id></mixed-citation>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zuo</surname><given-names>X</given-names></name><name><surname>Jing</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>2</issue>):<fpage>195</fpage>–<lpage>203</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.06.003</pub-id>
<pub-id pub-id-type="pmid">26253201</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725705454">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Daley</surname><given-names>TP</given-names></name><etal></etal></person-group>:
<article-title>CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2018</year>;<volume>23</volume>(<issue>5</issue>):<fpage>758</fpage>–<lpage>771.e8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2018.09.003</pub-id>
<!--<pub-id pub-id-type="pmcid">6214761</pub-id>-->
<pub-id pub-id-type="pmid">30318302</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734204708">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsunemoto</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Szűcs</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Diverse reprogramming codes for neuronal identity.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2018</year>;<volume>557</volume>(<issue>7705</issue>):<fpage>375</fpage>–<lpage>80</lpage>.
<pub-id pub-id-type="doi">10.1038/s41586-018-0103-5</pub-id>
<!--<pub-id pub-id-type="pmcid">6483730</pub-id>-->
<pub-id pub-id-type="pmid">29743677</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733204617">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torper</surname><given-names>O</given-names></name><name><surname>Pfisterer</surname><given-names>U</given-names></name><name><surname>Wolf</surname><given-names>DA</given-names></name><etal></etal></person-group>:
<article-title>Generation of induced neurons via direct conversion
<italic>in vivo</italic>.</article-title>
<source/><italic toggle="yes">Proc Natl Acad Sci U S A.</italic>
<year>2013</year>;<volume>110</volume>(<issue>17</issue>):<fpage>7038</fpage>–<lpage>43</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1303829110</pub-id>
<!--<pub-id pub-id-type="pmcid">3637783</pub-id>-->
<pub-id pub-id-type="pmid">23530235</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717992227">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoo</surname><given-names>AS</given-names></name><name><surname>Sun</surname><given-names>AX</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>MicroRNA-mediated conversion of human fibroblasts to neurons.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2011</year>;<volume>476</volume>(<issue>7359</issue>):<fpage>228</fpage>–<lpage>31</lpage>.
<pub-id pub-id-type="doi">10.1038/nature10323</pub-id>
<!--<pub-id pub-id-type="pmcid">3348862</pub-id>-->
<pub-id pub-id-type="pmid">21753754</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/12154957">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ladewig</surname><given-names>J</given-names></name><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Kesavan</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Small molecules enable highly efficient neuronal conversion of human fibroblasts.</article-title>
<source/><italic toggle="yes">Nat Methods.</italic>
<year>2012</year>;<volume>9</volume>(<issue>6</issue>):<fpage>575</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1038/nmeth.1972</pub-id>
<pub-id pub-id-type="pmid">22484851</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718061740">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lau</surname><given-names>S</given-names></name><name><surname>Rylander Ottosson</surname><given-names>D</given-names></name><name><surname>Jakobsson</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Direct Neural Conversion from Human Fibroblasts Using Self-Regulating and Nonintegrating Viral Vectors.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2014</year>;<volume>9</volume>(<issue>5</issue>):<fpage>1673</fpage>–<lpage>80</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.11.017</pub-id>
<pub-id pub-id-type="pmid">25482564</pub-id></mixed-citation>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pereira</surname><given-names>M</given-names></name><name><surname>Pfisterer</surname><given-names>U</given-names></name><name><surname>Rylander</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2014</year>;<volume>4</volume>:<fpage>6330</fpage>.
<pub-id pub-id-type="doi">10.1038/srep06330</pub-id>
<!--<pub-id pub-id-type="pmcid">4160709</pub-id>-->
<pub-id pub-id-type="pmid">25208484</pub-id></mixed-citation>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>CK</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Senescence impairs direct conversion of human somatic cells to neurons.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2014</year>;<volume>5</volume>:<fpage>4112</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms5112</pub-id>
<!--<pub-id pub-id-type="pmcid">4762026</pub-id>-->
<pub-id pub-id-type="pmid">24934763</pub-id></mixed-citation>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Paquola</surname><given-names>ACM</given-names></name><name><surname>Ku</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>6</issue>):<fpage>705</fpage>–<lpage>18</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.09.001</pub-id>
<!--<pub-id pub-id-type="pmcid">5929130</pub-id>-->
<pub-id pub-id-type="pmid">26456686</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725846218">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huh</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Victor</surname><given-names>MB</given-names></name><etal></etal></person-group>:
<article-title>Maintenance of age in human neurons generated by microRNA-based neuronal conversion of fibroblasts.</article-title>
<source/><italic toggle="yes">eLife.</italic>
<year>2016</year>;<volume>5</volume>: pii: e18648.
<pub-id pub-id-type="doi">10.7554/eLife.18648</pub-id>
<!--<pub-id pub-id-type="pmcid">5067114</pub-id>-->
<pub-id pub-id-type="pmid">27644593</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726758456">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfisterer</surname><given-names>U</given-names></name><name><surname>Ek</surname><given-names>F</given-names></name><name><surname>Lang</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Small molecules increase direct neural conversion of human fibroblasts.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2016</year>;<volume>6</volume>:<fpage>38290</fpage>
<pub-id pub-id-type="doi">10.1038/srep38290</pub-id>
<pub-id pub-id-type="pmid">27917895</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>DK</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>ML</given-names></name><etal></etal></person-group>:
<article-title>Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2016</year>;<volume>7</volume>(<issue>5</issue>):<fpage>955</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2016.09.013</pub-id>
<!--<pub-id pub-id-type="pmcid">5106529</pub-id>-->
<pub-id pub-id-type="pmid">28157484</pub-id></mixed-citation>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drouin-Ouellet</surname><given-names>J</given-names></name><name><surname>Lau</surname><given-names>S</given-names></name><name><surname>Brattås</surname><given-names>PL</given-names></name><etal></etal></person-group>:
<article-title>REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways.</article-title>
<source/><italic toggle="yes">EMBO Mol Med.</italic>
<year>2017</year>;<volume>9</volume>(<issue>8</issue>):<fpage>1117</fpage>–<lpage>31</lpage>.
<pub-id pub-id-type="doi">10.15252/emmm.201607471</pub-id>
<pub-id pub-id-type="pmid">28646119</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727747233">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Ansari</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>Mitochondrial Aging Defects Emerge in Directly Reprogrammed Human Neurons due to Their Metabolic Profile.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2018</year>;<volume>23</volume>(<issue>9</issue>):<fpage>2550</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.105</pub-id>
<!--<pub-id pub-id-type="pmcid">6478017</pub-id>-->
<pub-id pub-id-type="pmid">29847787</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/733308186">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herdy</surname><given-names>J</given-names></name><name><surname>Schafer</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons.</article-title>
<source/><italic toggle="yes">eLife.</italic>
<year>2019</year>;<volume>8</volume>: pii: e41356.
<pub-id pub-id-type="doi">10.7554/eLife.41356</pub-id>
<!--<pub-id pub-id-type="pmcid">6524968</pub-id>-->
<pub-id pub-id-type="pmid">31099332</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735781462">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chanda</surname><given-names>S</given-names></name><name><surname>Ang</surname><given-names>CE</given-names></name><name><surname>Davila</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Generation of induced neuronal cells by the single reprogramming factor ASCL1.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2014</year>;<volume>3</volume>(<issue>2</issue>):<fpage>282</fpage>–<lpage>96</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.05.020</pub-id>
<!--<pub-id pub-id-type="pmcid">4176533</pub-id>-->
<pub-id pub-id-type="pmid">25254342</pub-id></mixed-citation>
</ref>
<ref id="ref-64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Qiu</surname><given-names>B</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>2</issue>):<fpage>204</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.07.006</pub-id>
<pub-id pub-id-type="pmid">26253202</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725705453">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miskinyte</surname><given-names>G</given-names></name><name><surname>Devaraju</surname><given-names>K</given-names></name><name><surname>Grønning Hansen</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks.</article-title>
<source/><italic toggle="yes">Stem Cell Res Ther.</italic>
<year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>207</fpage>.
<pub-id pub-id-type="doi">10.1186/s13287-017-0658-3</pub-id>
<!--<pub-id pub-id-type="pmcid">5622454</pub-id>-->
<pub-id pub-id-type="pmid">28962665</pub-id></mixed-citation>
</ref>
<ref id="ref-66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Small molecule-based lineage switch of human adipose-derived stem cells into neural stem cells and functional GABAergic neurons.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2017</year>;<volume>7</volume>(<issue>1</issue>): 10166.
<pub-id pub-id-type="doi">10.1038/s41598-017-10394-y</pub-id>
<!--<pub-id pub-id-type="pmcid">5579051</pub-id>-->
<pub-id pub-id-type="pmid">28860504</pub-id></mixed-citation>
</ref>
<ref id="ref-67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2016</year>;<volume>291</volume>(<issue>26</issue>):<fpage>13560</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M115.709808</pub-id>
<!--<pub-id pub-id-type="pmcid">4919442</pub-id>-->
<pub-id pub-id-type="pmid">27137935</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726326991">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>SC</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Functional integration of dopaminergic neurons directly converted from mouse fibroblasts.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2011</year>;<volume>9</volume>(<issue>5</issue>):<fpage>413</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2011.09.011</pub-id>
<!--<pub-id pub-id-type="pmcid">3210333</pub-id>-->
<pub-id pub-id-type="pmid">22019014</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718061742">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caiazzo</surname><given-names>M</given-names></name><name><surname>Dell’Anno</surname><given-names>MT</given-names></name><name><surname>Dvoretskova</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2011</year>;<volume>476</volume>(<issue>7359</issue>):<fpage>224</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nature10284</pub-id>
<pub-id pub-id-type="pmid">21725324</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/11895956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2015</year>;<volume>6</volume>:<fpage>10100</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms10100</pub-id>
<!--<pub-id pub-id-type="pmcid">4672381</pub-id>-->
<pub-id pub-id-type="pmid">26639555</pub-id></mixed-citation>
</ref>
<ref id="ref-71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Victor</surname><given-names>MB</given-names></name><name><surname>Richner</surname><given-names>M</given-names></name><name><surname>Hermanstyne</surname><given-names>TO</given-names></name><etal></etal></person-group>:
<article-title>Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2014</year>;<volume>84</volume>(<issue>2</issue>):<fpage>311</fpage>–<lpage>23</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.016</pub-id>
<!--<pub-id pub-id-type="pmcid">4223654</pub-id>-->
<pub-id pub-id-type="pmid">25374357</pub-id></mixed-citation>
</ref>
<ref id="ref-72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Victor</surname><given-names>MB</given-names></name><name><surname>Richner</surname><given-names>M</given-names></name><name><surname>Olsen</surname><given-names>HE</given-names></name><etal></etal></person-group>:
<article-title>Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2018</year>;<volume>21</volume>(<issue>3</issue>):<fpage>341</fpage>–<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.1038/s41593-018-0075-7</pub-id>
<!--<pub-id pub-id-type="pmcid">5857213</pub-id>-->
<pub-id pub-id-type="pmid">29403030</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732609529">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vadodaria</surname><given-names>KC</given-names></name><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Paquola</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Generation of functional human serotonergic neurons from fibroblasts.</article-title>
<source/><italic toggle="yes">Mol Psychiatry.</italic>
<year>2016</year>;<volume>21</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2015.161</pub-id>
<pub-id pub-id-type="pmid">26503761</pub-id></mixed-citation>
</ref>
<ref id="ref-74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Direct conversion of human fibroblasts to induced serotonergic neurons.</article-title>
<source/><italic toggle="yes">Mol Psychiatry.</italic>
<year>2016</year>;<volume>21</volume>(<issue>1</issue>):<fpage>62</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1038/mp.2015.101</pub-id>
<!--<pub-id pub-id-type="pmcid">4518549</pub-id>-->
<pub-id pub-id-type="pmid">26216300</pub-id></mixed-citation>
</ref>
<ref id="ref-75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ichida</surname><given-names>JK</given-names></name><name><surname>Staats</surname><given-names>KA</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>BN</given-names></name><etal></etal></person-group>:
<article-title>Comparative genomic analysis of embryonic, lineage-converted and stem cell-derived motor neurons.</article-title>
<source/><italic toggle="yes">Development.</italic>
<year>2018</year>;<volume>145</volume>(<issue>22</issue>): pii: dev168617.
<pub-id pub-id-type="doi">10.1242/dev.168617</pub-id>
<!--<pub-id pub-id-type="pmcid">6262794</pub-id>-->
<pub-id pub-id-type="pmid">30337375</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/734254742">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Son</surname><given-names>EY</given-names></name><name><surname>Ichida</surname><given-names>JK</given-names></name><name><surname>Wainger</surname><given-names>BJ</given-names></name><etal></etal></person-group>:
<article-title>Conversion of mouse and human fibroblasts into functional spinal motor neurons.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2011</year>;<volume>9</volume>(<issue>3</issue>):<fpage>205</fpage>–<lpage>18</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2011.07.014</pub-id>
<!--<pub-id pub-id-type="pmcid">3188987</pub-id>-->
<pub-id pub-id-type="pmid">21852222</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/13484061">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>ML</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>CL</given-names></name></person-group>:
<article-title>Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2016</year>;<volume>14</volume>(<issue>1</issue>):<fpage>115</fpage>–<lpage>28</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.12.018</pub-id>
<!--<pub-id pub-id-type="pmcid">4706770</pub-id>-->
<pub-id pub-id-type="pmid">26725112</pub-id></mixed-citation>
</ref>
<ref id="ref-78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abernathy</surname><given-names>DG</given-names></name><name><surname>Kim</surname><given-names>WK</given-names></name><name><surname>McCoy</surname><given-names>MJ</given-names></name><etal></etal></person-group>:
<article-title>MicroRNAs Induce a Permissive Chromatin Environment that Enables Neuronal Subtype-Specific Reprogramming of Adult Human Fibroblasts.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2017</year>;<volume>21</volume>(<issue>3</issue>):<fpage>332</fpage>–<lpage>348.e9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2017.08.002</pub-id>
<!--<pub-id pub-id-type="pmcid">5679239</pub-id>-->
<pub-id pub-id-type="pmid">28886366</pub-id></mixed-citation>
</ref>
<ref id="ref-79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>ML</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons.</article-title>
<source/><italic toggle="yes">Front Mol Neurosci.</italic>
<year>2017</year>;<volume>10</volume>:<fpage>359</fpage>.
<pub-id pub-id-type="doi">10.3389/fnmol.2017.00359</pub-id>
<!--<pub-id pub-id-type="pmcid">5676779</pub-id>-->
<pub-id pub-id-type="pmid">29163034</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/732083910">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>JW</given-names></name><name><surname>Eade</surname><given-names>KT</given-names></name><name><surname>Szűcs</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Selective conversion of fibroblasts into peripheral sensory neurons.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2015</year>;<volume>18</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3887</pub-id>
<!--<pub-id pub-id-type="pmcid">4466122</pub-id>-->
<pub-id pub-id-type="pmid">25420069</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/725245146">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wainger</surname><given-names>BJ</given-names></name><name><surname>Buttermore</surname><given-names>ED</given-names></name><name><surname>Oliveira</surname><given-names>JT</given-names></name><etal></etal></person-group>:
<article-title>Modeling pain
<italic>in vitro</italic> using nociceptor neurons reprogrammed from fibroblasts.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2015</year>;<volume>18</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3886</pub-id>
<!--<pub-id pub-id-type="pmcid">4429606</pub-id>-->
<pub-id pub-id-type="pmid">25420066</pub-id></mixed-citation>
</ref>
<ref id="ref-82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Blum</surname><given-names>R</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Directing astroglia from the cerebral cortex into subtype specific functional neurons.</article-title>
<source/><italic toggle="yes">PLoS Biol.</italic>
<year>2010</year>;<volume>8</volume>(<issue>5</issue>):<fpage>e1000373</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000373</pub-id>
<!--<pub-id pub-id-type="pmcid">2872647</pub-id>-->
<pub-id pub-id-type="pmid">20502524</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/717999276">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Murenu</surname><given-names>E</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2016</year>;<volume>18</volume>(<issue>3</issue>):<fpage>396</fpage>–<lpage>409</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.12.003</pub-id>
<pub-id pub-id-type="pmid">26748418</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726066295">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rivetti Di Val Cervo</surname><given-names>P</given-names></name><name><surname>Romanov</surname><given-names>RA</given-names></name><name><surname>Spigolon</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Induction of functional dopamine neurons from human astrocytes
<italic>in vitro</italic> and mouse astrocytes in a Parkinson's disease model.</article-title>
<source/><italic toggle="yes">Nat Biotechnol.</italic>
<year>2017</year>;<volume>35</volume>(<issue>5</issue>):<fpage>444</fpage>–<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.1038/nbt.3835</pub-id>
<pub-id pub-id-type="pmid">28398344</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727495722">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4.</article-title>
<source/><italic toggle="yes">Stem Cells Transl Med.</italic>
<year>2015</year>;<volume>4</volume>(<issue>7</issue>):<fpage>755</fpage>–<lpage>63</lpage>.
<pub-id pub-id-type="doi">10.5966/sctm.2014-0289</pub-id>
<!--<pub-id pub-id-type="pmcid">4479625</pub-id>-->
<pub-id pub-id-type="pmid">25972144</pub-id></mixed-citation>
</ref>
<ref id="ref-86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.</article-title>
<source/><italic toggle="yes">Stem Cell Res.</italic>
<year>2016</year>;<volume>16</volume>(<issue>2</issue>):<fpage>236</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1016/j.scr.2016.01.016</pub-id>
<pub-id pub-id-type="pmid">26826927</pub-id></mixed-citation>
</ref>
<ref id="ref-87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Qiu</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Generation of neural progenitor cells by chemical cocktails and hypoxia.</article-title>
<source/><italic toggle="yes">Cell Res.</italic>
<year>2014</year>;<volume>24</volume>(<issue>6</issue>):<fpage>665</fpage>–<lpage>79</lpage>.
<pub-id pub-id-type="doi">10.1038/cr.2014.32</pub-id>
<!--<pub-id pub-id-type="pmcid">4042166</pub-id>-->
<pub-id pub-id-type="pmid">24638034</pub-id></mixed-citation>
</ref>
<ref id="ref-88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>YC</given-names></name><name><surname>Lim</surname><given-names>Y</given-names></name><name><surname>Duffieldl</surname><given-names>MD</given-names></name><etal></etal></person-group>:
<article-title>Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules.</article-title>
<source/><italic toggle="yes">Stem Cells Int.</italic>
<year>2016</year>;<volume>2016</volume>: 4304916.
<pub-id pub-id-type="doi">10.1155/2016/4304916</pub-id>
<!--<pub-id pub-id-type="pmcid">4695670</pub-id>-->
<pub-id pub-id-type="pmid">26788068</pub-id></mixed-citation>
</ref>
<ref id="ref-89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kwak</surname><given-names>TH</given-names></name><etal></etal></person-group>:
<article-title>Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts.</article-title>
<source/><italic toggle="yes">J Biol Chem.</italic>
<year>2016</year>;<volume>291</volume>(<issue>27</issue>):<fpage>14199</fpage>–<lpage>212</lpage>.
<pub-id pub-id-type="doi">10.1074/jbc.M115.713578</pub-id>
<!--<pub-id pub-id-type="pmcid">4933177</pub-id>-->
<pub-id pub-id-type="pmid">27189941</pub-id></mixed-citation>
</ref>
<ref id="ref-90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Sun</surname><given-names>YJ</given-names></name><etal></etal></person-group>:
<article-title>Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2016</year>;<volume>18</volume>(<issue>5</issue>):<fpage>653</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2016.03.020</pub-id>
<!--<pub-id pub-id-type="pmcid">4864020</pub-id>-->
<pub-id pub-id-type="pmid">27133794</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726325911">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>KA</given-names></name><name><surname>Kang</surname><given-names>PJ</given-names></name><etal></etal></person-group>:
<article-title>A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells.</article-title>
<source/><italic toggle="yes">Biochem Biophys Res Commun.</italic>
<year>2016</year>;<volume>476</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.05.080</pub-id>
<pub-id pub-id-type="pmid">27207831</pub-id></mixed-citation>
</ref>
<ref id="ref-92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>XL</given-names></name><name><surname>Yang</surname><given-names>JP</given-names></name><name><surname>Fu</surname><given-names>LN</given-names></name><etal></etal></person-group>:
<article-title>Direct reprogramming of porcine fibroblasts to neural progenitor cells.</article-title>
<source/><italic toggle="yes">Protein Cell.</italic>
<year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1007/s13238-013-0015-y</pub-id>
<!--<pub-id pub-id-type="pmcid">3938843</pub-id>-->
<pub-id pub-id-type="pmid">24492924</pub-id></mixed-citation>
</ref>
<ref id="ref-93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maucksch</surname><given-names>C</given-names></name><name><surname>Firmin</surname><given-names>E</given-names></name><name><surname>Butler-Munro</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts.</article-title>
<source/><italic toggle="yes">J Stem Cells Regen Med.</italic>
<year>2012</year>;<volume>8</volume>(<issue>3</issue>):<fpage>162</fpage>–<lpage>70</lpage>.
<!--<pub-id pub-id-type="pmcid">3908292</pub-id>-->
<pub-id pub-id-type="pmid">24693194</pub-id></mixed-citation>
</ref>
<ref id="ref-94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Ambasudhan</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells.</article-title>
<source/><italic toggle="yes">Cell Res.</italic>
<year>2014</year>;<volume>24</volume>(<issue>1</issue>):<fpage>126</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/cr.2013.156</pub-id>
<!--<pub-id pub-id-type="pmcid">3879704</pub-id>-->
<pub-id pub-id-type="pmid">24296783</pub-id></mixed-citation>
</ref>
<ref id="ref-95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mirakhori</surname><given-names>F</given-names></name><name><surname>Zeynali</surname><given-names>B</given-names></name><name><surname>Rassouli</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0135479</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0135479</pub-id>
<!--<pub-id pub-id-type="pmcid">4534403</pub-id>-->
<pub-id pub-id-type="pmid">26266943</pub-id></mixed-citation>
</ref>
<ref id="ref-96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Capetian</surname><given-names>P</given-names></name><name><surname>Azmitia</surname><given-names>L</given-names></name><name><surname>Pauly</surname><given-names>MG</given-names></name><etal></etal></person-group>:
<article-title>Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts.</article-title>
<source/><italic toggle="yes">Front Cell Neurosci.</italic>
<year>2016</year>;<volume>10</volume>: 245.
<pub-id pub-id-type="doi">10.3389/fncel.2016.00245</pub-id>
<!--<pub-id pub-id-type="pmcid">5075569</pub-id>-->
<pub-id pub-id-type="pmid">27822179</pub-id></mixed-citation>
</ref>
<ref id="ref-97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connor</surname><given-names>B</given-names></name><name><surname>Firmin</surname><given-names>E</given-names></name><name><surname>McCaughey-Chapman</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA.</article-title>
<source/><italic toggle="yes">Heliyon.</italic>
<year>2018</year>;<volume>4</volume>(<issue>11</issue>):<fpage>e00918</fpage>.
<pub-id pub-id-type="doi">10.1016/j.heliyon.2018.e00918</pub-id>
<!--<pub-id pub-id-type="pmcid">6226601</pub-id>-->
<pub-id pub-id-type="pmid">30450440</pub-id></mixed-citation>
</ref>
<ref id="ref-98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Jung</surname><given-names>WY</given-names></name><name><surname>Heo</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Exosome-Mediated Ultra-Effective Direct Conversion of Human Fibroblasts into Neural Progenitor-like Cells.</article-title>
<source/><italic toggle="yes">ACS Nano.</italic>
<year>2018</year>;<volume>12</volume>(<issue>3</issue>):<fpage>2531</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1021/acsnano.7b08297</pub-id>
<pub-id pub-id-type="pmid">29462562</pub-id></mixed-citation>
</ref>
<ref id="ref-99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>BE</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><etal></etal></person-group>:
<article-title>Single-Factor SOX2 Mediates Direct Neural Reprogramming of Human Mesenchymal Stem Cells via Transfection of
<italic>In Vitro</italic> Transcribed mRNA.</article-title>
<source/><italic toggle="yes">Cell Transplant.</italic>
<year>2018</year>;<volume>27</volume>(<issue>7</issue>):<fpage>1154</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1177/0963689718771885</pub-id>
<!--<pub-id pub-id-type="pmcid">6158546</pub-id>-->
<pub-id pub-id-type="pmid">29909688</pub-id></mixed-citation>
</ref>
<ref id="ref-100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grande</surname><given-names>A</given-names></name><name><surname>Sumiyoshi</surname><given-names>K</given-names></name><name><surname>López-Juárez</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Environmental impact on direct neuronal reprogramming
<italic>in vivo</italic> in the adult brain.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2013</year>;<volume>4</volume>:<fpage>2373</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms3373</pub-id>
<!--<pub-id pub-id-type="pmcid">3786770</pub-id>-->
<pub-id pub-id-type="pmid">23974433</pub-id></mixed-citation>
</ref>
<ref id="ref-101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faiz</surname><given-names>M</given-names></name><name><surname>Sachewsky</surname><given-names>N</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Adult Neural Stem Cells from the Subventricular Zone Give Rise to Reactive Astrocytes in the Cortex after Stroke.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>624</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.08.002</pub-id>
<pub-id pub-id-type="pmid">26456685</pub-id></mixed-citation>
</ref>
<ref id="ref-102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> reprogramming of astrocytes to neuroblasts in the adult brain.</article-title>
<source/><italic toggle="yes">Nat Cell Biol.</italic>
<year>2013</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1164</fpage>–<lpage>75</lpage>.
<pub-id pub-id-type="doi">10.1038/ncb2843</pub-id>
<!--<pub-id pub-id-type="pmcid">3867822</pub-id>-->
<pub-id pub-id-type="pmid">24056302</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718116540">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>ML</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> conversion of astrocytes to neurons in the injured adult spinal cord.</article-title>
<source/><italic toggle="yes">Nat Commun.</italic>
<year>2014</year>;<volume>5</volume>:<fpage>3338</fpage>.
<pub-id pub-id-type="doi">10.1038/ncomms4338</pub-id>
<!--<pub-id pub-id-type="pmcid">3966078</pub-id>-->
<pub-id pub-id-type="pmid">24569435</pub-id></mixed-citation>
</ref>
<ref id="ref-104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Miao</surname><given-names>Q</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>
<italic>Ascl1</italic> Converts Dorsal Midbrain Astrocytes into Functional Neurons
<italic>In Vivo</italic>.</article-title>
<source/><italic toggle="yes">J Neurosci.</italic>
<year>2015</year>;<volume>35</volume>(<issue>25</issue>):<fpage>9336</fpage>–<lpage>55</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3975-14.2015</pub-id>
<!--<pub-id pub-id-type="pmcid">6605193</pub-id>-->
<pub-id pub-id-type="pmid">26109658</pub-id></mixed-citation>
</ref>
<ref id="ref-105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>DK</given-names></name><etal></etal></person-group>:
<article-title>SOX2 reprograms resident astrocytes into neural progenitors in the adult brain.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2015</year>;<volume>4</volume>(<issue>5</issue>):<fpage>780</fpage>–<lpage>94</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2015.03.006</pub-id>
<!--<pub-id pub-id-type="pmcid">4437485</pub-id>-->
<pub-id pub-id-type="pmid">25921813</pub-id></mixed-citation>
</ref>
<ref id="ref-106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Tai</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2016</year>;<volume>17</volume>(<issue>3</issue>):<fpage>891</fpage>–<lpage>903</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.038</pub-id>
<!--<pub-id pub-id-type="pmcid">5094368</pub-id>-->
<pub-id pub-id-type="pmid">27732862</pub-id></mixed-citation>
</ref>
<ref id="ref-107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torper</surname><given-names>O</given-names></name><name><surname>Ottosson</surname><given-names>DR</given-names></name><name><surname>Pereira</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2015</year>;<volume>12</volume>(<issue>3</issue>):<fpage>474</fpage>–<lpage>81</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.040</pub-id>
<!--<pub-id pub-id-type="pmcid">4521079</pub-id>-->
<pub-id pub-id-type="pmid">26166567</pub-id></mixed-citation>
</ref>
<ref id="ref-108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2014</year>;<volume>14</volume>(<issue>2</issue>):<fpage>188</fpage>–<lpage>202</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2013.12.001</pub-id>
<!--<pub-id pub-id-type="pmcid">3967760</pub-id>-->
<pub-id pub-id-type="pmid">24360883</pub-id></mixed-citation>
</ref>
<ref id="ref-109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Bergami</surname><given-names>M</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2014</year>;<volume>3</volume>(<issue>6</issue>):<fpage>1000</fpage>–<lpage>14</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.10.007</pub-id>
<!--<pub-id pub-id-type="pmcid">4264057</pub-id>-->
<pub-id pub-id-type="pmid">25458895</pub-id></mixed-citation>
</ref>
<ref id="ref-110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De La Rossa</surname><given-names>A</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Golding</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> reprogramming of circuit connectivity in postmitotic neocortical neurons.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>200</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3299</pub-id>
<pub-id pub-id-type="pmid">23292682</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718061735">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rouaux</surname><given-names>C</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group>:
<article-title>Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons
<italic>in vivo</italic>.</article-title>
<source/><italic toggle="yes">Nat Cell Biol.</italic>
<year>2013</year>;<volume>15</volume>(<issue>2</issue>):<fpage>214</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1038/ncb2660</pub-id>
<!--<pub-id pub-id-type="pmcid">4118591</pub-id>-->
<pub-id pub-id-type="pmid">23334497</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718098538">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pereira</surname><given-names>M</given-names></name><name><surname>Birtele</surname><given-names>M</given-names></name><name><surname>Shrigley</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Direct Reprogramming of Resident NG2 Glia into Neurons with Properties of Fast-Spiking Parvalbumin-Containing Interneurons.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2017</year>;<volume>9</volume>(<issue>3</issue>):<fpage>742</fpage>–<lpage>51</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2017.07.023</pub-id>
<!--<pub-id pub-id-type="pmcid">5599255</pub-id>-->
<pub-id pub-id-type="pmid">28844658</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/729490400">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drouin-Ouellet</surname><given-names>J</given-names></name><name><surname>Pircs</surname><given-names>K</given-names></name><name><surname>Barker</surname><given-names>RA</given-names></name><etal></etal></person-group>:
<article-title>Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?</article-title>
<source/><italic toggle="yes">Front Neurosci.</italic>
<year>2017</year>;<volume>11</volume>:<fpage>530</fpage>.
<pub-id pub-id-type="doi">10.3389/fnins.2017.00530</pub-id>
<!--<pub-id pub-id-type="pmcid">5625013</pub-id>-->
<pub-id pub-id-type="pmid">29033781</pub-id></mixed-citation>
</ref>
<ref id="ref-114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>C</given-names></name><name><surname>Gascón</surname><given-names>S</given-names></name><name><surname>Masserdotti</surname><given-names>G</given-names></name><etal></etal></person-group>:
<article-title>Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex.</article-title>
<source/><italic toggle="yes">Nat Protoc.</italic>
<year>2011</year>;<volume>6</volume>(<issue>2</issue>):<fpage>214</fpage>–<lpage>28</lpage>.
<pub-id pub-id-type="doi">10.1038/nprot.2010.188</pub-id>
<pub-id pub-id-type="pmid">21293461</pub-id></mixed-citation>
</ref>
<ref id="ref-115">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pak</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Rapid single-step induction of functional neurons from human pluripotent stem cells.</article-title>
<source/><italic toggle="yes">Neuron.</italic>
<year>2013</year>;<volume>78</volume>(<issue>5</issue>):<fpage>785</fpage>–<lpage>98</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.029</pub-id>
<!--<pub-id pub-id-type="pmcid">3751803</pub-id>-->
<pub-id pub-id-type="pmid">23764284</pub-id></mixed-citation>
</ref>
<ref id="ref-116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Busskamp</surname><given-names>V</given-names></name><name><surname>Lewis</surname><given-names>NE</given-names></name><name><surname>Guye</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Rapid neurogenesis through transcriptional activation in human stem cells.</article-title>
<source/><italic toggle="yes">Mol Syst Biol.</italic>
<year>2014</year>;<volume>10</volume>(<issue>11</issue>):<fpage>760</fpage>.
<pub-id pub-id-type="doi">10.15252/msb.20145508</pub-id>
<!--<pub-id pub-id-type="pmcid">4299601</pub-id>-->
<pub-id pub-id-type="pmid">25403753</pub-id></mixed-citation>
</ref>
<ref id="ref-117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rubio</surname><given-names>A</given-names></name><name><surname>Luoni</surname><given-names>M</given-names></name><name><surname>Giannelli</surname><given-names>SG</given-names></name><etal></etal></person-group>:
<article-title>Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2016</year>;<volume>6</volume>: 37540.
<pub-id pub-id-type="doi">10.1038/srep37540</pub-id>
<!--<pub-id pub-id-type="pmcid">5114606</pub-id>-->
<pub-id pub-id-type="pmid">27857203</pub-id></mixed-citation>
</ref>
<ref id="ref-118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goparaju</surname><given-names>SK</given-names></name><name><surname>Kohda</surname><given-names>K</given-names></name><name><surname>Ibata</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Rapid differentiation of human pluripotent stem cells into functional neurons by mRNAs encoding transcription factors.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2017</year>;<volume>7</volume>: 42367.
<pub-id pub-id-type="doi">10.1038/srep42367</pub-id>
<!--<pub-id pub-id-type="pmcid">5304326</pub-id>-->
<pub-id pub-id-type="pmid">28205555</pub-id></mixed-citation>
</ref>
<ref id="ref-119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pawlowski</surname><given-names>M</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Bertero</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2017</year>;<volume>8</volume>(<issue>4</issue>):<fpage>803</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2017.02.016</pub-id>
<!--<pub-id pub-id-type="pmcid">5390118</pub-id>-->
<pub-id pub-id-type="pmid">28344001</pub-id></mixed-citation>
</ref>
<ref id="ref-120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Ward</surname><given-names>ME</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.</article-title>
<source/><italic toggle="yes">Stem Cell Reports.</italic>
<year>2017</year>;<volume>9</volume>(<issue>4</issue>):<fpage>1221</fpage>–<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stemcr.2017.08.019</pub-id>
<!--<pub-id pub-id-type="pmcid">5639430</pub-id>-->
<pub-id pub-id-type="pmid">28966121</pub-id></mixed-citation>
</ref>
<ref id="ref-121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M</given-names></name><name><surname>Chapani</surname><given-names>P</given-names></name><name><surname>Styan</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Functionalizing Ascl1 with Novel Intracellular Protein Delivery Technology for Promoting Neuronal Differentiation of Human Induced Pluripotent Stem Cells.</article-title>
<source/><italic toggle="yes">Stem Cell Rev.</italic>
<year>2016</year>;<volume>12</volume>(<issue>4</issue>):<fpage>476</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1007/s12015-016-9655-7</pub-id>
<pub-id pub-id-type="pmid">27138845</pub-id></mixed-citation>
</ref>
<ref id="ref-122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frega</surname><given-names>M</given-names></name><name><surname>van Gestel</surname><given-names>SHC</given-names></name><name><surname>Linda</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays.</article-title>
<source/><italic toggle="yes">J Vis Exp.</italic>
<year>2017</year>; (<issue>119</issue>): 54900.
<pub-id pub-id-type="doi">10.3791/54900</pub-id>
<!--<pub-id pub-id-type="pmcid">5407693</pub-id>-->
<pub-id pub-id-type="pmid">28117798</pub-id></mixed-citation>
</ref>
<ref id="ref-123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pak</surname><given-names>C</given-names></name><name><surname>Danko</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in
<italic>NRXN1</italic>.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>17</volume>(<issue>3</issue>):<fpage>316</fpage>–<lpage>28</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.07.017</pub-id>
<!--<pub-id pub-id-type="pmcid">4560990</pub-id>-->
<pub-id pub-id-type="pmid">26279266</pub-id></mixed-citation>
</ref>
<ref id="ref-124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Danko</surname><given-names>T</given-names></name><name><surname>Botelho</surname><given-names>SC</given-names></name><etal></etal></person-group>:
<article-title>Autism-associated SHANK3 haploinsufficiency causes I
<sub>h</sub> channelopathy in human neurons.</article-title>
<source/><italic toggle="yes">Science.</italic>
<year>2016</year>;<volume>352</volume>(<issue>6286</issue>):<fpage>aaf2669</fpage>.
<pub-id pub-id-type="doi">10.1126/science.aaf2669</pub-id>
<!--<pub-id pub-id-type="pmcid">4901875</pub-id>-->
<pub-id pub-id-type="pmid">26966193</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726211763">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Theka</surname><given-names>I</given-names></name><name><surname>Caiazzo</surname><given-names>M</given-names></name><name><surname>Dvoretskova</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors.</article-title>
<source/><italic toggle="yes">Stem Cells Transl Med.</italic>
<year>2013</year>;<volume>2</volume>(<issue>6</issue>):<fpage>473</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.5966/sctm.2012-0133</pub-id>
<!--<pub-id pub-id-type="pmcid">3673759</pub-id>-->
<pub-id pub-id-type="pmid">23658252</pub-id></mixed-citation>
</ref>
<ref id="ref-126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazzoni</surname><given-names>EO</given-names></name><name><surname>Mahony</surname><given-names>S</given-names></name><name><surname>Closser</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1219</fpage>–<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3467</pub-id>
<!--<pub-id pub-id-type="pmcid">3820498</pub-id>-->
<pub-id pub-id-type="pmid">23872598</pub-id></mixed-citation>
</ref>
<ref id="ref-127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wapinski</surname><given-names>OL</given-names></name><name><surname>Vierbuchen</surname><given-names>T</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><etal></etal></person-group>:
<article-title>Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2013</year>;<volume>155</volume>(<issue>3</issue>):<fpage>621</fpage>–<lpage>35</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2013.09.028</pub-id>
<!--<pub-id pub-id-type="pmcid">3871197</pub-id>-->
<pub-id pub-id-type="pmid">24243019</pub-id></mixed-citation>
</ref>
<ref id="ref-128">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aydin</surname><given-names>B</given-names></name><name><surname>Kakumanu</surname><given-names>A</given-names></name><name><surname>Rossillo</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>Proneural factors Ascl1 and Neurog2 contribute to neuronal subtype identities by establishing distinct chromatin landscapes.</article-title>
<source/><italic toggle="yes">Nat Neurosci.</italic>
<year>2019</year>;<volume>22</volume>(<issue>6</issue>):<fpage>897</fpage>–<lpage>908</lpage>.
<pub-id pub-id-type="doi">10.1038/s41593-019-0399-y</pub-id>
<!--<pub-id pub-id-type="pmcid">6556771</pub-id>-->
<pub-id pub-id-type="pmid">31086315</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/735751490">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-129">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Treutlein</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>QY</given-names></name><name><surname>Camp</surname><given-names>JG</given-names></name><etal></etal></person-group>:
<article-title>Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2016</year>;<volume>534</volume>(<issue>7607</issue>):<fpage>391</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1038/nature18323</pub-id>
<!--<pub-id pub-id-type="pmcid">4928860</pub-id>-->
<pub-id pub-id-type="pmid">27281220</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726404368">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-130">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mall</surname><given-names>M</given-names></name><name><surname>Kareta</surname><given-names>MS</given-names></name><name><surname>Chanda</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2017</year>;<volume>544</volume>(<issue>7649</issue>):<fpage>245</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1038/nature21722</pub-id>
<pub-id pub-id-type="pmid">28379941</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727478519">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-131">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Studer</surname><given-names>L</given-names></name><name><surname>Vera</surname><given-names>E</given-names></name><name><surname>Cornacchia</surname><given-names>D</given-names></name></person-group>:
<article-title>Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2015</year>;<volume>16</volume>(<issue>6</issue>):<fpage>591</fpage>–<lpage>600</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2015.05.004</pub-id>
<!--<pub-id pub-id-type="pmcid">4508309</pub-id>-->
<pub-id pub-id-type="pmid">26046759</pub-id></mixed-citation>
</ref>
<ref id="ref-132">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baek</surname><given-names>J</given-names></name><name><surname>Son</surname><given-names>H</given-names></name><name><surname>Jeong</surname><given-names>YH</given-names></name><etal></etal></person-group>:
<article-title>Chronological Aging Standard Curves of Telomere Length and Mitochondrial DNA Copy Number in Twelve Tissues of C57BL/6 Male Mouse.</article-title>
<source/><italic toggle="yes">Cells.</italic>
<year>2019</year>;<volume>8</volume>(<issue>3</issue>): pii: E247.
<pub-id pub-id-type="doi">10.3390/cells8030247</pub-id>
<!--<pub-id pub-id-type="pmcid">6468494</pub-id>-->
<pub-id pub-id-type="pmid">30875959</pub-id></mixed-citation>
</ref>
<ref id="ref-133">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horvath</surname><given-names>S</given-names></name></person-group>:
<article-title>DNA methylation age of human tissues and cell types.</article-title>
<source/><italic toggle="yes">Genome Biol.</italic>
<year>2013</year>;<volume>14</volume>(<issue>10</issue>):<fpage>R115</fpage>.
<pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
<!--<pub-id pub-id-type="pmcid">4015143</pub-id>-->
<pub-id pub-id-type="pmid">24138928</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718149288">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-134">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lo Sardo</surname><given-names>V</given-names></name><name><surname>Ferguson</surname><given-names>W</given-names></name><name><surname>Erikson</surname><given-names>GA</given-names></name><etal></etal></person-group>:
<article-title>Influence of donor age on induced pluripotent stem cells.</article-title>
<source/><italic toggle="yes">Nat Biotechnol.</italic>
<year>2017</year>;<volume>35</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>.
<pub-id pub-id-type="doi">10.1038/nbt.3749</pub-id>
<!--<pub-id pub-id-type="pmcid">5505172</pub-id>-->
<pub-id pub-id-type="pmid">27941802</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727097224">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-135">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Enhanced Rejuvenation in Induced Pluripotent Stem Cell-Derived Neurons Compared with Directly Converted Neurons from an Aged Mouse.</article-title>
<source/><italic toggle="yes">Stem Cells Dev.</italic>
<year>2015</year>;<volume>24</volume>(<issue>23</issue>):<fpage>2767</fpage>–<lpage>77</lpage>.
<pub-id pub-id-type="doi">10.1089/scd.2015.0137</pub-id>
<pub-id pub-id-type="pmid">26192905</pub-id></mixed-citation>
</ref>
<ref id="ref-136">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olova</surname><given-names>N</given-names></name><name><surname>Simpson</surname><given-names>DJ</given-names></name><name><surname>Marioni</surname><given-names>RE</given-names></name><etal></etal></person-group>:
<article-title>Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity.</article-title>
<source/><italic toggle="yes">Aging Cell.</italic>
<year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>e12877</fpage>.
<pub-id pub-id-type="doi">10.1111/acel.12877</pub-id>
<!--<pub-id pub-id-type="pmcid">6351826</pub-id>-->
<pub-id pub-id-type="pmid">30450724</pub-id></mixed-citation>
</ref>
<ref id="ref-137">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>JD</given-names></name><name><surname>Ganat</surname><given-names>YM</given-names></name><name><surname>Kishinevsky</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Human iPSC-based modeling of late-onset disease via progerin-induced aging.</article-title>
<source/><italic toggle="yes">Cell Stem Cell.</italic>
<year>2013</year>;<volume>13</volume>(<issue>6</issue>):<fpage>691</fpage>–<lpage>705</lpage>.
<pub-id pub-id-type="doi">10.1016/j.stem.2013.11.006</pub-id>
<!--<pub-id pub-id-type="pmcid">4153390</pub-id>-->
<pub-id pub-id-type="pmid">24315443</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718201428">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-138">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vera</surname><given-names>E</given-names></name><name><surname>Bosco</surname><given-names>N</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group>:
<article-title>Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation.</article-title>
<source/><italic toggle="yes">Cell Rep.</italic>
<year>2016</year>;<volume>17</volume>(<issue>4</issue>):<fpage>1184</fpage>–<lpage>92</lpage>.
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.062</pub-id>
<!--<pub-id pub-id-type="pmcid">5089807</pub-id>-->
<pub-id pub-id-type="pmid">27760320</pub-id></mixed-citation>
</ref>
<ref id="ref-139">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Doi</surname><given-names>A</given-names></name><name><surname>Wen</surname><given-names>B</given-names></name><etal></etal></person-group>:
<article-title>Epigenetic memory in induced pluripotent stem cells.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2010</year>;<volume>467</volume>(<issue>7313</issue>):<fpage>285</fpage>–<lpage>90</lpage>.
<pub-id pub-id-type="doi">10.1038/nature09342</pub-id>
<!--<pub-id pub-id-type="pmcid">3150836</pub-id>-->
<pub-id pub-id-type="pmid">20644535</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/4433956">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-140">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Polo</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Figueroa</surname><given-names>ME</given-names></name><etal></etal></person-group>:
<article-title>Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.</article-title>
<source/><italic toggle="yes">Nat Biotechnol.</italic>
<year>2010</year>;<volume>28</volume>(<issue>8</issue>):<fpage>848</fpage>–<lpage>55</lpage>.
<pub-id pub-id-type="doi">10.1038/nbt.1667</pub-id>
<!--<pub-id pub-id-type="pmcid">3148605</pub-id>-->
<pub-id pub-id-type="pmid">20644536</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/4844958">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-141">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abad</surname><given-names>M</given-names></name><name><surname>Mosteiro</surname><given-names>L</given-names></name><name><surname>Pantoja</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>Reprogramming
<italic>in vivo</italic> produces teratomas and iPS cells with totipotency features.</article-title>
<source/><italic toggle="yes">Nature.</italic>
<year>2013</year>;<volume>502</volume>(<issue>7471</issue>):<fpage>340</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12586</pub-id>
<pub-id pub-id-type="pmid">24025773</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/718106969">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-142">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>K</given-names></name><name><surname>Semi</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Premature termination of reprogramming
<italic>in vivo</italic> leads to cancer development through altered epigenetic regulation.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2014</year>;<volume>156</volume>(<issue>4</issue>):<fpage>663</fpage>–<lpage>77</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2014.01.005</pub-id>
<pub-id pub-id-type="pmid">24529372</pub-id></mixed-citation>
</ref>
<ref id="ref-143">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yilmazer</surname><given-names>A</given-names></name><name><surname>de Lázaro</surname><given-names>I</given-names></name><name><surname>Bussy</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> cell reprogramming towards pluripotency by virus-free overexpression of defined factors.</article-title>
<source/><italic toggle="yes">PLoS One.</italic>
<year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>e54754</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0054754</pub-id>
<!--<pub-id pub-id-type="pmcid">3552956</pub-id>-->
<pub-id pub-id-type="pmid">23355895</pub-id></mixed-citation>
</ref>
<ref id="ref-144">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In vivo</italic> reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury.</article-title>
<source/><italic toggle="yes">Sci Rep.</italic>
<year>2016</year>;<volume>6</volume>:<fpage>22490</fpage>.
<pub-id pub-id-type="doi">10.1038/srep22490</pub-id>
<!--<pub-id pub-id-type="pmcid">4783661</pub-id>-->
<pub-id pub-id-type="pmid">26957147</pub-id></mixed-citation>
</ref>
<ref id="ref-145">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ocampo</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Martinez-Redondo</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>
<italic>In Vivo</italic> Amelioration of Age-Associated Hallmarks by Partial Reprogramming.</article-title>
<source/><italic toggle="yes">Cell.</italic>
<year>2016</year>;<volume>167</volume>(<issue>7</issue>):<fpage>1719</fpage>–<lpage>1733.e12</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2016.11.052</pub-id>
<!--<pub-id pub-id-type="pmcid">5679279</pub-id>-->
<pub-id pub-id-type="pmid">27984723</pub-id></mixed-citation>
<note>
<p>
<ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727111268">F1000 Recommendation</ext-link>
</p>
</note>
</ref>
<ref id="ref-146">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larouche</surname><given-names>J</given-names></name><name><surname>Aguilar</surname><given-names>CA</given-names></name></person-group>:
<article-title>New Technologies To Enhance
<italic>In Vivo</italic> Reprogramming for Regenerative Medicine.</article-title>
<source/><italic toggle="yes">Trends Biotechnol.</italic>
<year>2019</year>;<volume>37</volume>(<issue>6</issue>):<fpage>604</fpage>–<lpage>17</lpage>.
<pub-id pub-id-type="doi">10.1016/j.tibtech.2018.11.003</pub-id>
<pub-id pub-id-type="pmid">30527703</pub-id></mixed-citation>
</ref>
<ref id="ref-147">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bruggeman</surname><given-names>KF</given-names></name><name><surname>Moriarty</surname><given-names>N</given-names></name><name><surname>Dowd</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Harnessing stem cells and biomaterials to promote neural repair.</article-title>
<source/><italic toggle="yes">Br J Pharmacol.</italic>
<year>2019</year>;<volume>176</volume>(<issue>3</issue>):<fpage>355</fpage>–<lpage>68</lpage>.
<pub-id pub-id-type="doi">10.1111/bph.14545</pub-id>
<!--<pub-id pub-id-type="pmcid">6329623</pub-id>-->
<pub-id pub-id-type="pmid">30444942</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>